integrated report year ended december essence management corporate philosophy corporate culture otsukapeople creating new products ryukangodo better health worldwide sweat recognize way process keeping corporate philosophy otsuka values ryukangodo sweat discovering core recognize way jissho actualization sozosei creativity strive substance something otsuka otsuka group supports lives people worldwide wide range hard work innovative creative products including pharmaceuticals functional beverages functional practice foods dedicated cultivating dynamic corporate culture workplaces reflect vision healthcare company finding ways live harmony local communities natural environment contributing richer healthier lives jissho actualization selfactualization otsukas goal achievement completion become indispensable contributor discovery truth peoples health worldwide otsuka group aims indispensable contributor peoples health worldwide fulfilling corporate philosophy every aspect operations commitment improving peoples sozosei health worldwide part unchanging value continue provide society operations creativity encompass two core businesses pharmaceutical business provides comprehensive health pursuing support diagnosis treatment diseases nutraceutical business helps people otsuka capable maintain improve daytoday health delivering nutraceuticals nutrition pharmaceuticalscontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report contents otsukas value creation create value facts data providing value businesses advancing unique total healthcare company financial nonfinancial highlights otsukas goal development pharmaceutical business esg content index total healthcare company nutraceutical business main data message ceo consumer products business businesses group structure global network feature corporate information message director charge sustainability year history otsuka group company organization health developing total healthcare company overview main operating companies people value creation model disclosure otsuka group quality value creation process generates originality stock information environment otsuka groups approach sustainability messages outside directors materiality material issues message cso message cfo governance corporate governance directors audit supervisory board members compliance tax compliance risk management th year symbol zeros made otsuka q quality quality refers promise guarantee create manufacture deliver products care customers trustcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report providing value businesses total healthcare company otsuka group contributes peoples health worldwide creating innovative products two core businesses pharmaceutical business aims address unmet medical needs nutraceutical business seeks fulfill yettobeimagined needs consumers unmet medical needs diagnosis treatment pharmaceutical business providing value otsuka bringing health people worldwide maintaining improving daytoday health nutraceutical business yettobeimagined needsotsukas goal development total healthcare company otsuka value creation sustainable society process unmet medical needs pharmaceutical business social wellbeing become indispensable contributor goal peoples health worldwide physical wellbeing mental wellbeing otsukas strengths achieve cosmedics cosmetics medicine state health defined constitution world health organization ylesolc ot sessenisub gnipoleved seussi laicos sserdda total healthcare ytilairetam contents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report pharma ceuticals nutra chemicals ceuticals otc cosmedics consumer clinical products nutrition medical diagnostics devices value creation model create value pages pages yettobeimagined needs nutraceutical business pages founding present futurecontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report message ceo otsukas centennial otsukas values otsuka group originated establishment continue chemical raw material manufacturer naruto build century tokushima prefecture japan although following years included tough times able progress help overcome challenges adhering concepts achieve sustainable espoused three generations leaders otsuka familyvalues always underpinned business society relevant today ever ryukangodo jissho sozosei otsuka ryukangodo sweat recognize way taken words otsuka founder busaburo otsuka things sweat toil discover truth essence instance problem quality magnesium carbonate earliest days tatsuo higuchi caused considerable frustration much head scratching experimenting solution discovered president representative director ceo quite coincidencea fortuitous accident would otsuka holdings co ltd occurred without everyday endeavors involved way unstinting effort helped create bedrock business jissho actualization inspired advice otsuka group companies celebrated th anniversary september reached masahito otsuka leader second generation milestone thanks support stakeholders including consumers patients medical hypothesize experiment achieve world pharmaceuticals drug satisfied percent professionals business partners local communities requirements regulatory approval still drug embark second century offer heartfelt thanks reconfirm determination yet approved might seem like measly every otsuka employee pursue otsuka thereby contributing peoples one percent could first indicator major flaw health worldwide project still long long way gocontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report message ceo masahito otsuka said life trumps laboratories since become otsuka challenges persevere pursue truths heart knowing referring need try many groups corporate philosophy days creativity matter approaches overcome challenges ensure final common byword akihiko otsuka saying onepercent gap bridged younger first four decades ago would judged heard words thought well creativity innovation calls greater creativity strategy stay abreast changing surely necessary study something innovation born conviction could external risks opportunities attempting later realized become worldclass pursuing projects location observing listening first companies found challenging result since appearance covid pandemic hand truly learn products made developing revolutionary products fact led outsized impact daytoday life also factories consumers react products instore blockbusters like abilify samscajinarcjynarque industrial structures business models consumers prefer particular product naturally creation newcategory products pocari included significant rapid change pharmaceutical need gather facts takes action parlay sweat calorie mate industry today faced myriad risks facts real awareness understanding three otsuka leaders shared common determination opportunities including geopolitical turmoil supply chain sozosei creativity comes akihiko otsuka leader always keep eye task hand appetite disruption rising raw material costs environmental third generation sentiment encapsulated hard work usually necessary get things problems population issues evolution artificial slogan otsukapeople creating new products done sometimes things turn planned intelligence computer technology hard better health worldwide adopted failures lie hints discoveries today always predict world look like future philosophy otsuka pharmaceuticals factories otsuka group corporate culture encourages people take otsuka group become indispensable contributor health people worldwide need envision society economy years years ahead agile response one could anticipate ways world ryukangodo jissho sozosei would change launched third mediumterm sweat recognize way actualization creativity management plan fiscal otsuka group companies never sat back accepted fateour process selfactualization pursuing discovering core achievement otsuka capable style always keep close eye substance something completion delivering developments adapt flexibly change hard work discovery truth appropriate enabled us adjust practice transformations brought pandemic still pursue business way consistent ourcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report message ceo management plan believe increase popular fiscal middle year third medium taking challenges awareness health issues amid new normal term management plan revenue tracked roughly line believe businesss three main drivers postcovid era presents us growth opportunities initial forecast business profit target philosophy culture capabilities people time us demonstrate true result agile approach prioritizing investments organization otsuka group corporate philosophy value unique total healthcare company growth nevertheless redouble efforts otsukapeople creating new products better health pharmaceutical business achieved push business profit beyond billion yen target worldwide remain universally applicable company revenue targets four global products set forth fiscal making roic return invested capital solid philosophical backbone strongest turbulent third mediumterm management plan two years ahead conscious investments managing sga expenses times remain dedicated seeking hard schedule moreover adapting changing landscape challenges unafraid change failure lessons carrying rd includes virtual clinical trials learn pursuit incorporated enhancing business continuity planning developing vision next years subsequent ventures thereby creating cycle enhances laborsaving technologies maintain stable supply capabilities individuals advances ability system manufacturing operating hybrid support stakeholders grounding manage organizations comprised individuals communication system sales combines inperson principles left us generations otsuka family leaders otsuka group unique total healthcare digital methodologies moreover continue enabled otsuka group companies thrive company contributed health people worldwide pursue innovation establishment otsuka century observance leaders timetased developing providing creative products services pharmaceuticals osaka pharmaceutical research institute wisdom must however coupled flexibility covering everything diagnosis treatment tentative name partnership sumitomo way view carry business may diseases health maintenance improvement moving dainippon pharma sumitomo pharma us adapt changes market keep technological forward increasing digitalization surely bring major subsidiary sunovion pharmaceuticals psychiatry advances respond geopolitical risks change industry drugs treatments neurology area hope keep changes operating environments fuse digital technology conventional healthcare nutraceutical business solidifying unable move times adapt methodologies advancements diagnosis presence consumer healthcare markets via strategy needs specific regions sustain growth must prediction disease strive provider focuses global expansion new concepts categories overcome preconceptions stereotypes comprehensive services products meet specific highprofitmargin products addition strategy energetically incorporate act diverse opinions healthcare needs community era sheer emphasizes taking advantage increased health dare achieve progress spark variety otsuka groups business portfolio gives us consciousness addressing new needs generated innovation seek innovation find foundation needed accelerate intragroup cooperation women playing active roles workplace insights generated diversity bold action joint ventures pursuit unwaveringcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report message ceo furthermore newly defined carbon neutrality services together business partners circular economy water neutrality environmental stakeholders strive live trust material issues set mediumterm targets responsibility invested us manufacturer promote nextlevel initiatives already working address fulfill unmet medical needs best accordance recommendations task force partner medical community consumers could hope climaterelated financial disclosures advisory board set otsuka group signed comprehensive g financial stability board companies partnership agreements prefectures municipalities analyze respond risks opportunities brought throughout japan help health climate change maintenance improvement activities support disaster preparation response efforts activities made possible groups position provider stakeholders unique total healthcare ideal opportunity us work closely local communities find humanity faced pandemics every time solutions challenges facing society pandemics major impact every time shareholders investors confident used wisdom technical innovations overcome continued commitment transparency fairness case covid challenge facing management strong governance world find way live virus framework appropriate disclosures accordance otsuka group seek always contribute society japans corporate governance code proactive otherwise would reason us exist dialogue continue live trust invested corporate philosophy convinced focusing company every day work hard toward goal us fulfill responsibilities society remain contributing peoples health help usher another inspired three generations leaders otsuka dedicated seeking sustained growth generating century sustained growth group sustainability family buoyed lofty aspirations steeled mediumtolongterm value accordance society unyielding determination corporate philosophy stance toward helping world overcome today patients consumers health sincerely ask continued support guidance environmental problems seen conscious ever part pursue stakeholders urge hold high sustainability mission launched business unwavering commitment contribute expectations next years otsuka group environmental vision net zero launched peoples health worldwide new products andcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report life realizing hidden power within feature year history otsuka group developing total healthcare company otsuka group celebrated th anniversary values cultivated long history enabled us take new endeavors businesses employees around world continue create new value people everywhere unwavering corporate philosophy otsukapeople creating new products better health worldwide photo courtesy tokushima prefectural museumcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report otsukas story billion since founding chemical raw material manufacturer otsuka group demonstrated outstanding creativity also honestly endeavored take path believes correct stay true values enabled pursue otsuka based valuesryukangodo sweat recognize way jissho actualization sozosei creativitygroup members spurred toward goal becoming unique total healthcare company addition responding changing times conditions continue contribute peoples health anticipating future trends developing businesses leverage uniqueness revenue pharmaceutical business nutraceutical business consumer products business businesses billion due change fiscal year results fiscal month period ended december medical cosmedics devices pharma nc ul tin rii tc ioa nl otc cen uu tt ir ca ls c po rn os du um cte sr nc ul tin rii tc ioa nl ceuticals c po rn os du um cte sr cp eh ua tr im caa ls diagnostics c po rn os du um cte sr diagnostics c po rn os du um cte sr pharmd ai agnostics cosmed cic os nsumer divb eu rss ii fin ce ts cc g aah gn bm n oi ec naa ais e u ts em f stac rh te em di c ta hls e iv chemi lca al us n chn c u el ti dn rii c oa nl nc ul tin rii tc ioa nl ch e mi ca ls otc nc ul cti enn ri ui uc ta ir cnl ls chemo ict ac ls cen uu tt ir ca ls chemicals otc nc ul tin rii tc ioa cnl en uu tt ir ca ls chemicalsotc cp eh ua tr nm c c uaa tis n rii tc ioa nl cen uu tt ir ca ls chemicao lstc ce ncu ut l ti ic n ra ii tcl oa nl cen uu tt ir ca ls chemicals p cducts bo ulu sit nio en sss oronine ointment oronl aa mun inch ced rink launched bon curry established p h armaceutical estab li sh e launche nn ersignal established ots u ka medical devices otc research institute otsuka assay laboratories otsuka group founded aiming growth otsuka group grown chemical raw otsuka group began proactively expanding provider wide variety science material manufacturer naruto businesses overseas maintain even backed products services city tokushima prefecture improve quality group insisted local meet healthcare needs times moved away singleproduct manufacturing addition providing countries regions serves manufacturing diversified products appropriate prices approach group launched new intravenous injection drip created jobs contributed local medical devices business infusion solutions communities otsukapeople creating new aiming globalization working pharmaceutical products factory founding era products better health worldwide contract signing ceremony develop ideal approach sold nationwide addition became philosophy groups china otsuka pharmaceutical age heightened concern pharmaceuticals group moved food housing domains thus factories research institutes otsuka group created new markets environment group successfully configured diverse foundations todays otsuka group built numerous unique products businesses diversified businesses generate value synergy founding era international expansion ss development onwardcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report founding era otsuka group begins otsuka seiyaku kogyobu founding pharmaceuticals food housing otsuka group began otsuka seiyaku kogyobu otsuka pharmaceutical taiho pharmaceutical otsuka founded september busaburo foods industry currently otsuka foods otsuka otsuka naruto city tokushima prefecture naruto city warehouse group companies established many salt pans hence group japans period rapid economic began business chemical raw material manufacturer growth addition earth corporation producing magnesium carbonate rubber additive groups operating infrastructure grew substantially oronamin c drink bittern byproduct salt production group launched carbonated energy drink oronamin c drink catchphrase genki entrance pharmaceutical business hatsuratsu full vitality born revolutionary nationwide expansion idea creating firstever carbonated energy drink complement steady growth chemical raw went become one groups familiar material manufacturer otsuka group entered busaburo otsuka longselling products pharmaceutical business group successively group launched worlds first retort launched new intravenous injection drip infusion pouch food product bon curry developed using expertise solutions expanded business throughout japan cultivated iv solutions business bon curry quickly furthermore diversifying businesses using became widely popular among japanese households bon curry technological expertise intravenous injection drip revolutionizing mealtimes infusion solutions chemical products intravenous injection infusion group launched sterilizerdisinfectant oronine ointment solutions time iv solutions business launched first overthecounter otc pharmaceutical established otsuka seiyaku kogyobu established taiho pharmaceutical renamed otsuka pharmaceutical factory established otsuka pharmaceutical entered intravenous injection drip launched otsuka foods industry currently otsuka foods equity infusion solutions business oronine ointment investment cbc foods industry launched tiovita drink established otsuka chemical medical products currently otsuka chemical launched oronamin c drink launched oronine ointment launched bon curry established otsuka warehouse equity investment earth corporation founding era international expansion ss development onwardcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report international expansion ss progress internationalization total healthcare internationalization birth pocari sweata replenishing drink leveraging rise yen us dollar developed replenish water electrolytes lost otsuka group began expanding overseas sights set perspiration ion supply drink pocari sweat one internationalization beginning establishment otsuka groups leading products went sale thai otsuka pharmaceutical first office us palo group decided go blue packaging alto group expanded europe indonesia product despite color considered taboo color taiwan egypt china today otsuka group soft drinks japan time initially receive inauguration ceremony approximately employees working companies thai otsuka pharmaceutical positive response however result continuous visits countries regions worldwide december sports venues supermarkets public baths saunas similar pocari sweat places communicate importance replenishing water inhouse drug discovery electrolytes lost perspiration promote desire create pharmaceuticals would contribute value product addressing issue pocari sweat global healthcare group established research enjoyed countries worldwide institute within otsuka pharmaceuticals tokushima factory predominantly japan countries asia began inhouse drug discovery discovered potential carbostyril structure mikelan meptin worlds first art museum housing ceramic group launched first inhouse drug beta reproductions major works art blocker mikelan went release bronchodilator march otsuka group marked th anniversary meptin mucosta gastritis gastric ulcers evolving opening otsuka museum art inhouse rd production structure process built educational tourism purposes otsuka museum art art museum world house established thai otsuka pharmaceutical fullsize ceramic reproductions major works art groups first overseas operating company mucosta around world reproduction sistine chapel ceiling opened first office us otsuka museum art launched futraful opened first offices europe established pt otsuka indonesia launched calorie mate established taiwan otsuka pharmaceutical established otsuka pakistan established arab otsuka pharmaceutical established otsuka america currently egypt otsuka pharmaceutical established otsuka america pharmaceutical launched pocari sweat pharmavite joined otsuka group launched mikelan meptin launched mucosta established china otsuka pharmaceutical anticancer drug futraful established otsuka museum art nutritionally balanced food established korea otsuka pharmaceutical launched match throughout japan calorie mate established otsuka pharmaceutical europe founding era international expansion ss development onwardcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report development onward becoming true total healthcare company otsuka group continue provide value meets needs times countries regions serves aim helping resolve social issues contributions unique otsuka providing value meet new needs since launching abilifythe worlds first dopamine partial agonist psychiatric recent years addition heightened awareness importance health increasing treatmentin us otsuka pharmaceutical gone develop sell attention paid environmentally friendly food products otsuka group diverse range unique products services countries regions moving address needs products early stage theme social worldwide include samscajinarcjynarque original drug disease contribution us daiya foods develops manufactures sells plantbased food known treatment met need diuretic promotes products growing result firm support individuals strong health awareness excretion water without electrolyte loss moreover oncology areaa central new healthrelated values well food allergies addition nutrition sant pillar groups pharmaceutical businessotsuka pharmaceutical taiho pharmaceutical offers range healthy foods including freefrom food products alternative food astex pharmaceuticals strategically sharing unique advanced technologies products countries worldwide mainly europe japan group also sells independently cultivated linking technologies many years expertise variety healthy environmentally friendly products include bon curry veggie series experience otsuka group aims drive sales four global products future products contain animalderived ingredients two zero meat hamburger products growth aiming address unmet needs fulfilled pharmaceuticals alone first japan acquire jas certification soy meat foods soyjoy group also developing unique medical devices combining strengths pharmaceuticals plantbased series acquired vegan certification use plantbased ingredients clinical development revolutionary technologies otsuka group food products contain free specific ingredients example foods contain gluten striving growth unrivaled total healthcare company glutenfree launched os launched equelle launched abilify us launched rexulti us launched aminovalue launched bodymaint launched soyjoy launched zero meat gerbl products daiya foods nutrition sant established otsuka holdings launched biomimics launched samscajinarcjynarque us japan europe launched soyjoy otsuka holdings listed first section plantbased series soyjoy plantbased series tokyo stock exchange established otsuka medical devices launched abilify maintena us launched lonsurf zero meat bon curry veggie founding era international expansion ss development onwardcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report challenge new frontiers otsuka addressing unmet needs initiatives womens health market aiming generate innovation creative diverse research platforms addition existing womens empowerment society progresses otsuka group seeks create world strengths otsuka pharmaceutical using cell gene therapies regenerative medicine every individual play active role end group focusing biologics immune system research advanced digital technologies highly innovative drug initiatives tackle womens health issues throughout life discovery fields immunology oncology neurodegenerative therapy group provides sciencebacked products equelle dietary supplement efforts promote close collaboration information exchange companies containing equol supports womens health beauty time aging brings physical inside outside group otsuka pharmaceutical open osaka mental changes tocoelle complex supplement address psychological physical pharmaceutical research institute research hub create value global perspective premenstrual symptoms experienced around women bup lady first otc pharmaceutical japan accredited effective urinary urgency women group also publishes womens health health management information meanwhile usbased uqora specialist provider products urinary healtha particular concern many womenhas joined otsuka group enable group support women even wider range fields group stay closely attuned individual needs work provide solutions womens unique health issues image osaka pharmaceutical research institute equelle tocoelle products uqora visterra joined otsuka group companys proprietary hierotope platform technologies antibody development use entirely different approach conventional methods using approach otsuka group aims design develop therapeutic antibodies drug discovery targets bup lady diseases considered untreatable group intends provide pharmaceuticals address unmet medical needs founding era international expansion ss development onwardcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report value creation model inputs outcomes providing stakeholder value human capital employees approx japan approx consumers outside japan approx corporate philosophy sustainability mission outputs value creation process social revenue fiscal relationship capital pharma billion patients total group companies ceuticals j oa ta sn id e japan chemicals cen uu tt ir ca ls products services pharmaceutical business business sites countriesregions therapeutic drugs healthcare clinical nutrition products professionals unique diagnostics medical devices otc cosmedics bringing health manufactured capital diverse nutraceutical business people worldwide manufacturing sites businesses functional beverages japan foods cosmedics otc shareholders products quasidrugs outside japan investors consumer clinical products nutrition consumer products business beverages foods alcoholic beverages intellectual capital diagnostics medical devices businesses research sites chemicals fine chemicals employees japan warehouse distribution outside japan sustainability mission packaging electronic equipment total co emissions fiscal financial capital tco suppliers ryukangodo jissho sozosei total assets billion natural capital local communities energy consumption society kl water consumption december reinvestment allocation capital data companies including otsuka holdings subsidiaries affiliated companies manufacturing sites consolidated otsuka groupcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report providing stakeholder value initiatives fiscal expand product access contribute resolution unmet needs innovation consumers countriesregions antituberculosis drug delamanid available new drugs approved patients countriesregions antipsychotic drug abilify maintena sold development projects unmet needs healthcare professionals otsuka pharmaceutical formulated otsuka global patient access support policy research development expenses billion july inhouse drug discovery ratio maintain sound financial foundation deliver stable returns shareholders shareholders credit rating aa annual dividend per share investors de ratio provide new information net cash average monthly consolidated revenue months business briefings institutional investors create vibrant workplace environments enhance employee engagement group companies recognized certified health productivity female manager ratio otsuka holdings management outstanding organizations meti employees employees taking parental leave group companies enhance measures respect human rights male employees taking parental leave total formulated implemented otsuka group human rights policy march offered necessary training promote sustainable procurement companies attended supplier briefings suppliers suppliers implementing selfassessment questionnaire saq interviews held suppliers enhance system realization healthy lifestyles reassess use raw materials executed cooperation agreements prefectures japan promotion launch pet bottles made using recycled materials local collaboration health awareness activities otsuka pharmaceutical environmental management communities provide support covid pandemic formulated environmental vision net zero society donated relief goods funds revised mediumterm goals targets material issues increase utilization renewable energy announced support recommendations task force climate reduction co emissions adoption renewable energy tco related financial disclosure tcfd carried scenario analyses quick navi flucovid ag otsuka minor bcrabl mrna measurement kit ajovy moizerto domestic otsuka holdings otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical otsuka warehouse unmet needs areas defined otsuka based patientsmapjp patientsmapus ssri otsuka chemical otsuka foods otsuka medical devices otsuka electronics otsuka techno okayama taiho pharmaceutical inhouse drug discovery ratio among latephase development projects phase onward otsuka packaging industries otsuka ohmi ceramics higashiyama film otsuka wellness vending jimro overseas otsuka pharmaceutical development commercialization otsuka america pharmaceutical pharmavite rating investment information inc otsuka holdings otsuka pharmaceutical taiho pharmaceutical earth corporation otsuka pharmaceutical factory otsuka net cash cash cash equivalents borrowings bonds pharmaceutical health insurance association otsuka medical devices otsuka wellness vending otsuka electronics jimro briefing tuberculosis initiatives briefing daiya business institutional investors briefing pharmavite business institutional investors briefing materials visit httpswwwotsukacomenirlibrarybriefinghtmlcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report value creation process generates originality taking challenge otsuka originality otsuka generated combination unique diverse businesses attempting create new value using unique standing total healthcare company involved diverse businesses new original value products utilize links businesses services create new domains diverse businesses existing businesses otsuka group boasts wealth human resources diverse expertise experience rather enter existing markets accumulated various technological create new markets scientific assets company thought take pharma ceuticals nutra diversifying needs chemicals ceuticals changes brought times environmental changes unique otc cosmedics changes healthrelated notions diverse anticipate needs arise changes businesses consumer clinical products nutrition medical diagnostics devicescontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report value creation process generates originality otsuka otsukas strengths people source strengths since otsukas establishment employees everywhere pursued business guided enduring corporate philosophy order bring health people worldwide determination developed many strengths six strengths described representative sample otsuka group employees utilize strengths working maximize effects contributing health people around world enduring corporate philosophy essence management unwavering quest originality ability nurture enduring brands passed practiced throughout group topshare products pharmaceutical category inhouse drug discovery ratio countriesregions japan outside japan corporate philosophy displayed prominently development projects offices every country region unmet needs projects eh xpar ee r io enf cc eo n os fu um sie nr gs w poit ch rh ie weat business communication corporate philosophy continue take challenge revolutionary developing products brand tenaciously essence management otsuka employees around products services striving creativity value communicating value revolutionary products world work otsuka contribute chains always looking opportunities make unique aim sustainable growth health people worldwide otsuka innovations enhancement corporate value inhouse drug discovery ratio among latephase development projects copyright iqvia created based annual category totals phase onward past years including iqvia midas otsuka research december unmet needs areas defined otsuka based categories defined otsuka reprinted permission patientsmapjp patientsmapus ssri november survey japan conducted otsuka business model centered global reach incorporating solutions social solid financial foundation strong total healthcare issues core business processes earnings power drive sustainable growth iv solutions business overseas companies aa social wellbeing rating physical wellbeing countriesregions mental wellbeing pocari sweat available b nu us ti rn ae cs es u p tir co af l bt um sa inrg esin f countriesregions antituberculosis contributing three aspects health drug delamanid available provide variety sciencebased products services extending global reach addressing social cultivating solid financial foundation strong meet specific healthcare needs times issues differ countryregion depending earnings power whereby nutraceuticals iv solutions community culture customs times generate stable earnings act base therapeutic agents driver growth fund number companies engaged iv solutions business many companies also export products neighboring countries thereby ongoing investment creative new areas befitting otsuka making meaningful contribution medical care countries rating investment information inc average previous three years reference average operating profit margin sp food beverage select industry index constituents previous three years otsuka group determined material issues society health people quality environment carbon neutrality circular economy water neutrality governance worked group achieve goals sustainability mission address social issues evolution toward healthier sustainable society simultaneously achieving growth activities supported comprehensive governance system contribution sustainable society map social issues compiled list social issues relevant otsuka groups businesses created map social issues considering importance terms sustainability degree otsukas business fully synchronized efforts address social issues impact business activities high environment healthier planet society healthier society carbon neutrality circular economy health people quality water neutrality global warming spread infectious diseases governance risks stemming corporate governance compliance risk management social change lack response consumption production diversification impairs sustainability increase environmental impact fragile governance system presenteeism degree impact business activities high ytilibaniatsus ot drager htiw ecnatropmi contents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report creating future value leads originality otsuka groups approach sustainability identification social issues reference respective international guidelines assessment social issues business activities contribute solving importance determination material issues sustainability promotion committee viewpoint impact society otsuka group approval otsuka holdings board directors meeting sustainability promotion committee promotes sustainability throughout otsuka group committees responsibilities include discussing deciding direction plans sustainability activities otsuka holdings director charge sustainability promotion serves committee chair committee members comprise group managers departments relating sustainability sustainability officers company increase issues caused population aging nutritional needs unmet medical health needs reduced freshwater availability due water process determining materiality material issues resource risks materiality initiatives otsuka focused determine otsuka groups material issues first compiled list social issues referencing range international guidelines frameworks including iso gri un sdgs narrowed list issues evaluating terms importance taking account ability contribute solution impact business strengths issues discussed sustainability promotion committee approved otsuka holdings board directors meeting issues bold nine priority social issues situation despite coming work productivity increase due employees poor mental physical conditioncontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report otsuka groups approach sustainability relationship materiality mediumterm management plan description materiality description mtm plan corporate philosophy sustainability mission longterm fy goals contribute challenge new frontiers promotion rd unmet needs resolution unmet needs otsuka address unmet needs psychiatry neurology areas health create firstinclass products cardiovascular renal area areas unmet needs generate innovation creative new development projects diverse research platforms latephase development projects advancing next phase eradication tuberculosis provide delamanid cases supply deltyba generic name delamanid pediatric patients launch clinical trial new treatment regimen increase access delamanid collaborating partners creation system challenge new categories create new systems reinforce existing realization healthy lifestyles new areas systems realization healthy lifestyles create new concepts products keeping healthy life extension maintain highprofit structure eye changes environments health people quality carbon neutrality circular economy water neutrality governancecontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report materiality material issues social materiality social issues goals activities related sdgs fy goals fy progress issues promotion rd unmet needs areas unmet needs address unmet needs psychiatry neurology areas new development projects projects create firstinclass products oncology area latephase development projects advancing next phase projects create firstinclass products cardiovascular renal area areas unmet needs new development projects promotion rd unmet needs latephase development projects advancing next phase unmet medical health needs contribution resolution unmet needs rd antitubeculosis drugs improvement drug access provide delamanid cases provided delamanid cases ahead schedule countriesregions continued participation pantb collaboration accelerated development health nsp ur te ra itd io nf ln nf ee ect dio sus diseases e cr ra ed ai tc ioa nti f ao f ytu stb ee mrc fu olo r ti hs e realization hu ep alp tho r mt ind ea nw aa nr ce en e imss p roc vti ev miti ee ns tf mr p ae ino lyp l oe ns lau np cly h e cl lit ny icb ala tr iag le fn oe rr nc e n wa tree td mel ea nm ren gid im f eo nr pediatric patients dee tl et rmyb ina ed tp op cro ov ne dd u cfo r c lp ine id ci aa lt tr ric ia p l foti nn ets w n ru er eo p de ru gn co oc mto bb ine ar io n therapy regimen includes df e n lae mw nb id r se ua pt pm lie en dt tr rg oi um ge hn global drug facility gdf stop tb increase issues caused healthy lifestyles exercise nutrition etc increase access delamanid collaborating partners opc delamanid partnership alliance partners population aging healthy life extension promotion problem solving strengthening continued participation global health innovative technology fund ghit fund partnerships challenge new categories new areas executed comprehensive cooperation agreements health prefectures japan ongoing provision kenko shacho healthy president service create new systems reinforce existing systems realization local governments promoted collaboration health fields expanded dietary education communicate importance good nutrition society healthy lifestyles raised awareness proper hydration electrolyte replenishment support disasters emergencies healthier create new concepts products keeping eye changes continued hold womens health seminars support tokyo marathon society environments years publishing otsuka health comic library support interhigh school championships cumulative total oathas registrants approximately instill corporate culture philosophy cumulative total participants executive human resource development programs otsuka global total number attendees groupwide diversity seminars human resource development build systems ongoing human resource development aligned academy oga implemented otsuka group human rights policy offered necessary training presenteeism creation corporate culture stimulates creativity people diversity promotion changes society times cumulative total participants health seminars approximately lack response diversification enhance employee engagement health productivity management promote instill diversity source innovation build new systems maintain comfortable working environments sustainable procurement product design suppliers implementing selfassessment questionnaire saq cumulative total companies implementing saq held global product quality meeting gaining stakeholder trust thorough quality control stable supply pursuing sustainability levels value chain cumulative total companies participating supplier briefings formulated nc global quality policy quality consumption production pursuing sustainability levels value chain r esponsible promotional activities information provision sustainable procurement stable supply products covid pandemic improved products based customer feedback impairs sustainability establishing quality assurance system safety deepening communication stakeholders conduct supplier briefings suppliers held global production meeting manufacturing errors workshop environmental security promotion consumeroriented management original goal timescompanies fiscal management information exchange meeting c na er ub ran l ity global warming arget reduce co emissions compared reduce co emissions throughout value chain e r ne ed ru gc ye ec ffo ic ee nm cyissions introducing renewable energy maximizing tn cn fo du n ac ne dd cs au rp rp ieo dr f uo tr rt ih ske nc ao lym sem sendations task force climaterelated financial disclosure cn os mta pll le ed ec ing te rn oe dr ua ct tio ion n oys f ce om fa ren ed efu lee cl c rio cn itv ye r tio e q u dp om en st tic factories five reduce co emissions throughout value chain group companies target reduce simple incineration reduce environmental impact improving reduce environmental impact enhanced resource efficiency began sales pet bottles using recycled pet resin circular landfill disposal compared resource efficiency promote business activities aim social environmental environmental load increase economy target content recycled plant promotion business activities aimed sustainability environment based materials pet bottles sustainability society earth healthier target expand plant water management analyze ascertain risks regarding sustainable water usage formulated plan create water resource management program planet water reduced freshwater availability program locations globally understanding water resource risks ensure effective use management water resources neutrality due water resource risks target develop water use strategy management effective use water resources business locations waterstressed areas build system strengthen compliance within group carried activities directors raise effectiveness reinforced efforts improve efficacy crisis management strengthen corporate governance fragile governance system strengthen corporate governance raise effectiveness board directors meeting attendance rate reinforced response overseas risks governance longterm improvement corporate value thorough compliance social change risk build governance system capable global business development implemented otsuka group global antifraud policy improved level information security group company risk identification evaluation management response various changes launched basic cyber security training program situation despite coming work productivity increase due employees poor mental physical condition sustainable energy use sustainable use raw materials sustainable use water resourcescontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report fiscal goals fiscal progress among social issues determined otsuka groups materiality selected nine issues regard especially important present set goals related fiscal social materiality social issues goals activities related sdgs fy goals fy progress issues promotion rd unmet needs areas unmet needs address unmet needs psychiatry neurology areas new development projects projects create firstinclass products oncology area latephase development projects advancing next phase projects create firstinclass products cardiovascular renal area areas unmet needs new development projects promotion rd unmet needs latephase development projects advancing next phase unmet medical health needs contribution resolution unmet needs rd antitubeculosis drugs improvement drug access provide delamanid cases provided delamanid cases ahead schedule countriesregions c ontinued participation pantb collaboration accelerated development health n sp ur te ra itd io nf ln nf ee ect dio sus diseases e cr ra ed ai tc ioa nti f ao f ytu stb ee mrc fu olo r ti hs e realization hu ep alp tho r mt ind ea nw aa nr ce en e imss p roc vti ev miti ee ns tf mr p ae ino lyp l oe ns lau np cly h e cl lit ny icb ala tr iag le fn oe rr nc e n wa tree td mel ea nm ren gid im f eo nr pediatric patients dee tl et rmyb ina ed tp op cro ov ne dd u cfo r c lp ine id ci aa lt tr ric ia p l foti nn ets w n ru er eo p de ru gn co oc mto bb ine ar io n therapy regimen includes f e n lae mw nb id r se ua pt pm lie en dt tr rg oi um ge hn global drug facility gdf stop tb increase issues caused healthy lifestyles exercise nutrition etc increase access delamanid collaborating partners opc delamanid partnership alliance partners population aging healthy life extension promotion problem solving strengthening continued participation global health innovative technology fund ghit fund partnerships challenge new categories new areas executed comprehensive cooperation agreements health prefectures japan ongoing provision kenko shacho healthy president service create new systems reinforce existing systems realization local governments promoted collaboration health fields expanded dietary education communicate importance good nutrition society healthy lifestyles raised awareness proper hydration electrolyte replenishment support disasters emergencies healthier create new concepts products keeping eye changes continued hold womens health seminars support tokyo marathon society environments years publishing otsuka health comic library support interhigh school championships cumulative total oathas registrants approximately instill corporate culture philosophy cumulative total participants executive human resource development programs otsuka global total number attendees groupwide diversity seminars human resource development build systems ongoing human resource development aligned academy oga implemented otsuka group human rights policy offered necessary training p resenteeism creation corporate culture stimulates creativity people diversity promotion changes society times cumulative total participants health seminars approximately lack response diversification enhance employee engagement health productivity management promote instill diversity source innovation build new systems maintain comfortable working environments sustainable procurement product design suppliers implementing selfassessment questionnaire saq cumulative total companies implementing saq held global product quality meeting gaining stakeholder trust thorough quality control stable supply pursuing sustainability levels value chain cumulative total companies participating supplier briefings formulated nc global quality policy quality consumption production pursuing sustainability levels value chain r esponsible promotional activities information provision sustainable procurement stable supply products covid pandemic improved products based customer feedback impairs sustainability establishing quality assurance system safety deepening communication stakeholders conduct supplier briefings suppliers held global production meeting manufacturing errors workshop environmental security promotion consumeroriented management original goal timescompanies fiscal management information exchange meeting c na er ub ran l ity global warming arget reduce co emissions compared reduce co emissions throughout value chain e r ne ed ru gc ye ec ffo ic ee nm cyissions introducing renewable energy maximizing tn cn fo du n ac ne dd cs au rp rp ieo dr f uo tr rt ih ske nc ao lym sem sendations task force climaterelated financial disclosure cn os mta pll le ed ec ing te rn oe dr ua ct tio ion n oys f ce om fa ren ed efu lee cl c rio cn itv ye r tio e q u dp om en st tic factories five reduce co emissions throughout value chain group companies target reduce simple incineration reduce environmental impact improving reduce environmental impact enhanced resource efficiency began sales pet bottles using recycled pet resin circular landfill disposal compared resource efficiency promote business activities aim social environmental environmental load increase economy target content recycled plant promotion business activities aimed sustainability environment based materials pet bottles sustainability society earth healthier target expand plant water management analyze ascertain risks regarding sustainable water usage formulated plan create water resource management program planet water reduced freshwater availability program locations globally understanding water resource risks ensure effective use management water resources neutrality due water resource risks target develop water use strategy management effective use water resources business locations waterstressed areas build system strengthen compliance within group carried activities directors raise effectiveness reinforced efforts improve efficacy crisis management strengthen corporate governance fragile governance system strengthen corporate governance raise effectiveness board directors meeting attendance rate reinforced response overseas risks governance longterm improvement corporate value thorough compliance social change risk build governance system capable global business development implemented otsuka group global antifraud policy improved level information security group company risk identification evaluation management response various changes launched basic cyber security training program cumulative total since cumulative total since otsuka advanced training healthy aging supporters program supports pharmacies health information includes carbonneutral electricity utilizing certificates equal renewable energy emit co hubs strong connections local communities otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical otsuka chemical otsuka foods december contents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report message cfo brands nutraceutical business overcoming loss revenue due expiration major copromotion agreements business profit billion yen practice business decrease billion yen previous year solid management awareness growth existing businesses outweighed capital cost pursue increase expenses due onetime factors early sustainable growth deployment investments growth roe roic enhanced corporate value initial targets middle year third maximizing business value mediumterm management plan billion yen making investments growth revenue billion yen business profit roe higher excluding aforementioned expenses due onetime factors revenue would target business profit target roe target yuko makino results third mediumterm management plan executive director cfo otsuka holdings co ltd fiscal targets revenue billion business profit billion cagr roe higher progress third mediumterm progress middle year fiscal billion management plan third mediumterm management plan fiscal business impacted variety events overview plan covid pandemic soaring raw material prices period third mediumterm management plan supply chain disruptions able positioned fiveyear growth phase advance overcome issues harnessing strengths global market unique total healthcare company conducting broadranging business unique total oorr hhiigghheerr wh ee wph ila l r mm aa xc imeu izti ec el x b isu tis nin ge bss u sa nd es sh n luu et r aa nc de u ct ri ec aa tl e b nu esi wne ss hea wlth ec ar ce h c ieo vm edp rn ey v enue billion yen year higher value conduct business management corporate increase billion yen previous year wide awareness capital cost thereby maintain mainly increase around billion yen revenue e e sustainable growth time making four global products pharmaceutical revenue business profit cagr roe investments growth ensuring returns shareholders business three major brands three nurture announced february announced may contents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report message cfo however variety risksincluding relating pursue progress toward targets line third creation core businesses pharmaceuticals geopolitics interest rates exchange rate fluctuation mediumterm management plan nutraceuticals conscious capital costs continue make unpredictable operating business operations commitment lead maximizing environment fiscal beyond keep cash returns existing business allocating generated close eye potential impact business measures enhancing corporate value cash reinvest future growth areas appropriately respond flexibly timely manner meet targets making stable ongoing shareholder returns mediumterm management plan maximizing existing business value third mediumterm management plan roic management work implement corporatewide awareness capital plan fiscal one aim third mediumterm management plan cost set weighted average cost made upfront investments period embed commitment throughout group focus capital wacc benchmark otsuka group including fiscal foresee growth four maximization existing business value well new value focusing embedding roic management global products third mediumterm management plan order secure framework financial strategies pharmaceutical business stable returns business activities excess cost well pocari sweat capital addition pursuing maximization revenues supplements returns excess cost capital aim achieve better cost management improved nutraceutical business business management tailored business product roic wacc therefore fiscal efficient asset liability management forecast revenue closely aligned balance sheetone major billion yen yearonyear cash flow generation cash allocation factors roic management thoroughly implementing increase billion yen approach lead higher cash returns businesses forecast business profit business investments specific measures aimed establishing roic management profit growth billion yen yearonyear operating reinvestment outlined cash flows increase billion yen improvement capital led ongoing growth ccc expenditure maximizing revenues existing businesses existing businesses maximize revenues two core businesses increased revenue new debt financing dividends pharmaceutical business nutraceutical shareholder product launches forecast returns business pharmaceutical business two reduction share buybacks roe yearonyear nonoperating assets years ahead schedule achieved final year increase points revenue targets four global products roic yearonyear mediumterm management plan nutraceutical external debt shareholders equity increase points business aiming faster growth optimal capital structure major expansion three major brands better conveying value provided three nurture cash conversion cycle brands supplement business particular higher optimal mix external borrowing shareholders equitymessage cfo levels health consciousness greater trust structure encompasses operations multiple financing perspective stabilize brands quality generating revenue growth regionsjapan north america europe asia china financial base improve capital efficiency reducing also looking expand shared services strengthen interestbearing debt external financing required cost efficiency existing businesses platform promote intragroup financing casebycase basis based comprehensive launched pharmaceutical products set optimize procurement functions one example assessment cost time required access selling general administrative sga expense ratio intragroup financing adoption cash management funds balance terms debttoequity ratio targets seek make efficient use costs system region system leads efficient metrics credit rating way ensure optimal carefully controlling expenses goal sga funding among otsuka group companies region balance interestbearing debt shareholders expense ratio final year third mediumterm reduces need external borrowing reduces interest equity capital structure management plan approximately aim payments contributes ability generate cash embed thorough roic management groupwide achieve ahead time must improve shortterm capital efficiency nutraceutical business amid aggressive corporate department initiatives region mediumtolongterm corporate value well investment competitors striving efficient financial standpoint must build stable financial base initiatives region disciplined control costs unique methods order continue otsuka communicating product value japan established otsuka business support standardization efficiency initiatives human resources accounting roic management invested capital perspective north standardization efficiency initiatives human resources america procurement finance centered otsuka america invested capital operating approach established otsuka holdings europe germany began europe standardization efficiency initiatives work processes operating liabilities invested working capital etc capital financing asia standardization sharing initiatives finance work processes operating assets approach china efficiency initiatives human resources finance audit working capital interest financing compliance work processes centered otsuka china investment fixed assets etc bearing debt borrowings bonds cost debt close eye balance sheet interest payments looking invested capital assets perspective emphasize efficient management operating assets shareholders creditors nonoperating equity strive maintain appropriate inventory levels control assets cost equity working capital strengthen management fixed assets expected returns corporate department initiatives periodically review shares held business strategic corporate department supports cost efficiency purposes meanwhile continue address issue returns excess optimal capital indirect departments smooth business operations nonoperating assets including idle fixed assets either cost capital structure enhancing business foundation groupwide finding ways make effective use strengthening governance management businesses selling increased mediumtolongterm corporate value stnemtsevni srotsevni contents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report sga expense ratio pharmaceutical products already market approx approx approx aa e e year average third mediumterm management plan actual results fiscal plancontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report message cfo business profits pharmaceutical base turn help us contribute society paving impending patent expiration second medium nutraceutical businesses way innovation term management plan period also fund investments billion organic growth nutraceutical business framework financial strategies support business segment pharmaceutical business pharmaceutical new value creation directing funds toward ongoing investments rd aimed business source funds investments growth enhancing products pipelines core areas principle investments growth funded psychiatry neurology area oncology area reinvestment cash returns generated businesses cardiovascular renal area addition investments effective use funds cash targeted creating new value meet unmet medical needs nutraceutical management system established within otsuka group including diseases existing therapeutic drugs new business europe north america japan external concepts integrate drugs digital technologies procurement cash required always prepared abilify mycite medical devices apply new implement full range options including commercial approaches ultrasound renal denervation treatment second mediumterm third mediumterm management plan management plan paper corporate bonds bank loans share issues refining manufacturing technologies enhancing product selecting optimal approach take account quality implementing rationalization measures clinical factors credit rating financial security cost nutrition business achieved stable cash generation businesss steady generation profits enabled time required thereby ensuring ability act japanese market link success overseas growth group whole sustain stable growth timely manner business opportunities arise markets allocating funds business area also regional market shareholder returns policy allocation funds growth investments nutraceutical business reallocating cash basic policy shareholder returns maintain stable otsuka group see investment vehicle earned three major brands creation new dividends emphasizing continuity stability pursuing innovation enables us contribute society categories expanding new regions build dividends carefully consider amount dividends continue pursue investments potential brands strengthen manufacturing marketing comprehensively weigh issues appropriate levels increase corporate value social contribution structures three nurture brands making proactive retained cash investments growth maintaining solid reallocating funds investment position continues investments better convey value products financial standing achieving optimal capital structure funds need necessarily allocated within aggressive investments pharmaceutical core tenet financial strategy original portfolio segment specific business nutraceutical businesses established continued issue stable dividends third medium product region within pharmaceutical business structure two businesses term management plan period despite shortterm nutraceutical business different segments inseparablelike two wheels cartbut also capable fluctuations performance moving forward consider help cash investment supporting terms revenues profit shareholder returns depending circumstances instance abilify generated largescale revenues period third mediumterm management include outlook investments growth cash abilify used diversify plan pharmaceutical business susceptible targeting increased profit subsequent mediumterm pharmaceutical businesss revenue structure promote ups downs revenues profits due factors management plans groups overall financial situation globalization business avert risk expiration exclusive licenses nutraceuticalcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report create value advancing unique total healthcare company progress third mediumterm management plan comprehensive provider diverse range sciencebased products services otsuka groups growth underpinned dedication overview fiscal addressing healthcare needs accordance times characteristics fiscal third year third mediumterm management plan saw ongoing social communities serve social issues faced countries regions differ uncertainty due covid pandemic also impact otsuka groups depending local cultures customs constantly evolving identifying business activities however despite restrictions sales activity reduced consumption helping resolve changing social issues continue expand globally took heightened health awareness growth opportunity leveraged true value devoted supplying products services help countries unique total healthcare company result maintained solid growth achieving revenue regions overcome challenges billion yen increase previous year business strategy revenue business segment existing business value maximization new value creation strengthen strategic initiatives growth drivers four global products pharmaceutical business three major brands three nurture brands nutraceutical business fy pharmaceutical business l aunch nurture new drivers sustainable growth pharmaceutical nutraceutical businesses nutraceutical business consumer products business billion businesses performance target business profit cagr organic growth mainstay products brands pharmaceutical nutraceutical businesses ctively invest rd continue creating new drugs drive revenue outcomes progress beyond next mediumterm management plan total healthcare company disseminate provide new value unique total healthcare company response new social issues caused pandemic revenue billion adapt environmental changes tailor third mediumterm management plan third mediumterm results management plan targets business profit billion cagr fiscal results progressing line third mediumterm management plan targets fy pharmaceuticals four global products sales achieved third mediumterm management plan targets two years roe higher ahead schedule nutraceuticals profitability reached one highest japanese food sector growth strategy strengthen pipeline psychiatry neurology area enrich pipeline japan business nutraceuticals new categories womens health plantbased foods achieve nature made target billionyenbrandcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report advancing unique total healthcare company among otsuka groups materialities set specific goals three healthrelated social issues unmet medical health needs spread infectious diseases nutritional needs third mediumterm management plan ending fiscal making progress toward meeting goals social issues unmet medical health needs spread infectious diseases nutritional needs goals contribute resolution unmet needs eradication tuberculosis creation system realization healthy lifestyles promotion rd unmet needs address unmet needs psychiatry neurology areas create firstinclass products oncology area provide delamanid cases challenge new categories new areas create firstinclass products cardiovascular renal area supply deltyba generic name delamanid pediatric patients create new systems reinforce existing systems realization fy goals healthy lifestyles areas unmet needs launch clinical trial new treatment regimen create new concepts products keeping eye changes new development projects increase access delamanid collaborating partners environments latephase development projects advancing next phase executed cooperation agreements health prefectures japan local governments promoted collaboration provided delamanid cases ahead schedule health fields countriesregions raised awareness proper hydration electrolyte replenishment deltyba approved pediatric patients europe october continued hold womens health seminars areas unmet needs et ar pm yi n ree gd mto e nco tn hd au c int cc uin di eca l tr pia cl f r n e w ah nre de dd er lau mg ac im dbination years publishing otsuka health comic library fy progress new development projects projects continued participation pantb collaboration accelerated cumulative total oathas registrants approximately latephase development projects advanced next phase development new tb treatment regimen ongoing provision kenko shacho healthy president service projects delamanid supplied global drug facility gdf expanded dietary education communicate importance good stop tb partnership alliance partners nutrition continued participation global health innovative support disasters emergencies technology fund ghit fund support tokyo marathon support interhigh school championships unmet needs areas defined otsuka based patientsmapjp patientsmapus ssri cumulative total since contents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report advancing unique total healthcare company pharmaceutical business third mediumterm management plan calls us began six new development projects projects since progress third mediumterm management plan maximize existing business value challenge new frontiers fiscal advanced six latephase development otsuka generate projects next phase projects since fiscal billion innovation creative diverse research platforms unmet needs areas defined otsuka based patientsmapjp take advantage strategic framework position patientsmapus ssri four global productsabilify maintena rexulti progress four global products samscajinarcjynarque lonsurfas growth four global products expanded regions added drivers focus increasing revenue indications overseas worked increase awareness global products continue develop business convenient dosage formulations drugs revenue work achieve plan target billion yen fiscal rose previous year billion revenue fiscal yen achieving billion yen target third medium e e otsuka group focuses unmet medical health term management plan two years ahead schedule rd mtm plan needs social issue fiscal unmet needs areas four global products pharmaceutical business growth future fy fy fy billion yearonyear growth rate revenue revenue revenue plan abilify maintena rexulti samscajinarcjynarque lonsurf total abilify maintena rexulti aripiprazole antipsychotic longacting injectable brexpiprazole atypical antipsychotic global treatment schizophrenia increased awareness drugs efficacy claims marketed adjuvant treatment major depressive disorder treatment schizophrenia convenient dosage formulation following us approval additional indication us drug highly evaluated efficacy safety new treatment option treatment bipolar disorder prescriptions increasing prescriptions also increasing diseases japan drug marketed treatment schizophrenia began sales japan following approval additional indication treatment bipolar disorder orally disintegrating tablets november europe sales began april september present several clinical trials way aim contributing treating unmet needs psychiatry neurology areacontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report advancing unique total healthcare company samscajinarcjynarque lonsurf tolvaptan vreceptor antagonist trifluridinetipiracil anticancer agent samsca highly evaluated various guidelines japan prescriptions increasing lonsurf treatment option unresectable advanced recurrent colorectal cancer treatment cardiac edema hepatic edema prescriptions treatment autosomal december approved countries regions prescriptions increasing dominant polycystic kidney disease adpkd intractable renal disease increasing owing furthermore combination therapy bevacizumab listed recommended treatment promotion proper use guidelines disease awareness activities drug also option national comprehensive cancer network nccn guidelines colon cancer contributed resolving unmet needs following approval additional indication january rectal cancer december us japanese society cancer syndrome inappropriate antidiuretic hormone secretion siadh june colon rectum jsccr guidelines january meanwhile also treatment may jynarque launched us treatment adpkd efforts raise option metastatic gastric cancer number countries regions lonsurf disease awareness make clinical trial data available helped spread recognition approved total number prescriptions increasing maximize disease drug leading steady increase prescriptions europe jinarc sold value currently conducting several clinical studies develop better combination therapies approximately countries number patients receiving treatment drug national comprehensive cancer network nonprofit alliance leading cancer centers us increase devoted patient care research education global operation adpkd drug role lonsurf medical settings lonsurf thirdline subsequent chemotherapy option patients colorectal gastric cancers addition efficacy oral agent believe provides additional value due convenience enables patients spend less time receiving treatment time outside medical facility launched approx contributed approx important field oncology support treatment chisato mashita countries patients specialists frontline work closely assistant section identify patients needs although pandemic made manager difficult gather communicate information medical yokohama sales settings otsuka group enhancing cooperative framework contributed approx branch ethical drug patients sales section means include sharing information group taiho pharmaceutical companies something otsuka group utilizing unique group synergy aim quickly carefully communicate essential information improve quality life patients families estimated number adpkd patients us europe japan december inhouse surveycontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report advancing unique total healthcare company future pharmaceutical business opportunities risks future initiatives disruptions caused global conflicts factors risks affect pharmaceutical business include backdrop addition working reduce risks pharmaceutical business taking challenges relating reduced visits medical institutions delayed reinforcing supply chains ensure stable product new areas utilize unique qualities clinical development due global covid pandemic suppliesthe otsuka group contribute resolution otsuka group working address unmet needs generate paradigm shifts treatment caused advances digital social issues initiatives targeting diseases innovation using creative diverse research platforms technologies medical cost inflation supply chain unmet needs working develop systematic solutions optimize medical care furthermore form alliances promote open innovation work venture capital firms reinforce drug discovery foundation diversify modalities strengths weaknesses also seek strengthen supply chains securing backup providing total healthcare solutions diagnosis treatment delays registering trial participants due specific problems global rd marketing assets psychiatry neurology field psychiatry neurology caused spread suppliers enhancing accuracy sales forecasts area renal area covid promote development marketing activities use digital presence oncology area patent expiration mainstay products technologies stable profit iv solutions business dependence manufacturing sites raw material suppliers medical techniques using digital technologies production contractors concentrated specific regions addition strive improve profitability originality free fixed ideas trength w eakness maximizing value existing products carry trials new projects actively invested second third mediumterm management plans develop new opportunities threats products aim grow pipelines advances science technology progress basic global drug price control policies promotion generic drug drive development onward achieve research related diseases use due medical cost inflation creation synergies therapeutic drugs advances intensifying competition core areas sustainable growth digital technologies pandemic related spread infectious diseases promotion precision medicoines enhance efficacy supply chain disruptions due geopolitical riskts factors pportunity hreatcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report advancing unique total healthcare company psychiatry neurology oncology aiming become topclass global player psychiatry neurology maximizing business value proprietary drug discovery platforms area highpotential pipeline product portfolio initiatives new drug discovery technologies methodologies psychiatric diseases schizophrenia bipolar disorder major depressive disorder taiho pharmaceuticals broad product portfolio supported proprietary drug discovery develop age affect persons social life career studies moreover platform technologies including biochemical modulation technology continued concerns increase alzheimers disease world population ages diseases develop throughout history cysteinomix drug discovery platform enables specific affect patients quality life also place strain family members covalent modification therapeutic targets fragmentbased drug discovery platform caregivers well healthcare economy still many psychiatric neurological established astex pharmaceuticals one example futibatinib discovered using diseases satisfactory treatments yet established causes cysteinomix drug discovery platform granted breakthrough therapy designation mechanisms fully understood makes discovery new drugs extremely us fda march fda also accepted new drug application futibatinib difficult otsuka group entered psychiatry neurology area priority review likewise pimitespib approved japans ministry health labour continued take challenge new drug discovery goal contributing welfare indication gastrointestinal stromal tumors progressed medical needs chemotherapy taiho pharmaceutical also accelerating drug development resolve unmet otsuka group developed extensive highpotential pipeline needs collaborating partner companies furthermore looks opportunities product lineup application small molecule large molecule compound collaboration promising startups corporate venture capitals thereby expanding technologies digital technologies aim become topclass global player development pipelines cancer immunotherapy areas acquiring innovative drug psychiatry neurology area discovery platform technologies meanwhile centering external collaborations otsuka pharmaceutical taking challenge establishing new therapies focus future includes creating synergies agitation associated dementia alzheimers type new modalities areas genemodified cell therapies estimated approximately million people estimated us individual group companies combining accumulated assets fields strength alzheimers disease thought large number patients exhibit bolster global operations enhance business value form behavioral disorder agitation excessive motor activity verbal p latform discovering compounds specifically form covalent bond reactive amino acid residues mainly cysteine physical aggression kind disorder places burden patients caregivers residues protein potential drug target proteins impacting quality life otsuka group aims market worlds first treatment echnology create new compounds molecular design clarifies interactions smallmolecular fragments showing pharmacological activity measured highthroughput screening large molecule proteins agitation associated dementia alzheimers type clinical trials way complicated structures implicated diseases potential drug targets two drugs different mechanisms action brexpiprazole avp hope therapeutic development projects contribute physical wellbeing patients also mental wellbeing social wellbeing including caregivers become solution realization sustainable society drdecision resources llc rights reserved reproduction distribution transmission publication prohibitedcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report advancing unique total healthcare company cardiovascular renal system antituberculosis drug research development creating firstinclass products new drug discovery technologies delamanid improving global health one first new drugs years medical devices nobody otsuka must cardiovascular renal area addition strengthening proprietary drug discovery delamanid one newest antituberculosis drugs approved world past platforms also plan actively make growth investments examples included years although mdrtb currently gaining prominent attention thought tb business alliance aurinia pharmaceuticals voclosporin acquisition visterra become disease humankind already overcome since rifampicin currently used company renal diseaserelated pipeline combining expertise pharmaceuticals one firstline drugs discovered many researchers medical device technologies also develop medical devices minimally invasive less research institutes around world stopped development otsuka pharmaceutical continued impactful body launched biomimics vascular stent system japan research based belief tb serious global health problem must continue meanwhile ultrasound renal denervation system revolutionary treatment method patients research nobody else delamanid created years otsuka high blood pressure existing treatments proved ineffective granted pharmaceutical remains actively engaged rd new antituberculosis drugs breakthrough device designation us fda treatment bears ce mark europe decade company consistently ranked among top funders tb rd worldwide clinical trials way us japan moving forward aim provide firstinclass products innovative approaches nextgeneration tuberculosis drug candidate opc displayed products conform relevant health safety environmental protection standards specified otsuka pharmaceutical conducting research antituberculosis drugs follow eu legislation delamanid latest development compound called opc undergoing phase ii trials south africa confirm safety efficacy opc kills tb focusing building otsukas kidney franchise bacteria mechanism inhibits activity enzymes essential since joining otsuka visterra endeavored grow synthesizing mycobacterium tuberculosis cell walls mechanism action differs capabilities biologicsbased drug discovery accelerate completely existing antituberculosis drugs including delamanid expected medicines clinical testing continue develop stateof effective treatment various strains tb developing drug received grants theart machine learning algorithms expedite workflows bill melinda gates foundation cited elimination tb worldwide one employ innovative scientific strategies create novel top priorities advance clinical trials continue engaging tb rd aim antibodybased designs successful collaboration medical teams establishing innovative treatment methods zachary shriver visterra otsuka continue advance investigational chief scientific officer medicines even challenges presented covid pandemic collective efforts led several noteworthy visterra successes sibeprenlimab vis progressed rapidly phase iii clinical trials treatment iga nephropathy serious autoimmune disease kidney recently awarded orphan drug designation european medicines agency addition vis drug intended regulate autoimmune responses recently granted regulatory permission initiate clinical trials given recent successes look forward continued collaboration expanding upon otsukas franchise nephrology immunologycontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report advancing unique total healthcare company major development progress product indication countryregion progress psychiatry neurology brexpiprazole schizophrenia pediatric patients us approved fremanezumab migraine japan approved aripiprazole longacting injectable schizophrenia china filed centanafadine smoking cessation us started phase ii us implemented phase iii ulotaront schizophrenia japan implemented phase iiiii sep bipolar depression japanus implemented phase iii oncology pimitespib gastrointestinal stromal tumor japan filed fosnetupitant chemotherapyinduced nausea vomiting japan filed cholangiocarcinoma japanuseurope started phase iii futibatinib urothelial cancer us europe started phase ii tas solid tumors harboring germline pten inactivating mutations japanuseurope started phase ii astx acute myeloid leukemia us started phase ii opc multiple myeloma japan started phase iii tas acute myeloid leukemia us started phase cardiovascular renal system opc cardiac edema japan filed voclosporin lupus nephritis europe filed bempedoic acid hypercholesterolemia japan started phase ii obesity us started phase categories difamilast atopic dermatitis japan approved pamufetinib chronic fibrosing interstitial lung diseases progressive phenotype japan started phase iicontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report advancing unique total healthcare company nutraceutical business third mediumterm management plan calls revenue furthermore working maintain highprofit structure progress three major brands growth billion yen three major brandspocari capable sustained business profit margin higher pocari sweat sweat nature made nutrition santand billion strategies include creating new product concepts anticipation despite effect restrictions due covid yen three nurture brandsbodymaint equelle changes business landscapes expanding new pandemic consumer activity sales volume pocari daiya categories new regions accelerating global expansion sweat beverage replenishing fluids electrolytes increasing particularly overseas due awarenessraising revenue third mediumterm management plan rd mtm plan activities market development tailored conditions billion revenue three major brands three nurture brands region japan addition regular activities global new products operations new businesses revenue nutraceutical business raise awareness heat disorder countermeasures new business profit margin activities included providing support running interhigh school championships alljapan junior high business profit margin school championships also communicated maintain higher importance measures prevent spread infectious diseases public understanding importance build resilient business foundation replenishing fluids electrolytes home also increasing revenue growing steadily result nd mtm plan three nurture brands asiapacific sports beverage market expanded review management assets three major brands cagr however expect outpace market underpin value chain growth forecasting cagr overseas revenue e e pocari sweat period third mediumterm third mediumterm management plan management plan accelerating global expansiontrends overseas revenue sports beverage market asiapacific furthermore given higher levels health consciousness strengthening global sales structure expand billion japan north america europe others overseas us million asiapacific revenue ratio cagr new regions expect growth demand health pocari sweat beverages future aim grow pocari sweat overseas overseas revenue plan revenue ratio cagr billionyen brand enhancing brand strength japan original marketing thoroughly communicates cagr product concept japan china indonesia south korea thailand malaysia others philippines vietnam taiwan euromonitor international uk contents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report advancing unique total healthcare company nature made nutrition sant launched pharmavite llc californiabased corporation engaged supplement nutrition sant ns founded pioneer european health food specific research development nature made supplement brand sold us manufacturing sant means health french companys objective provide better stores nutrition keep consumers healthy ns factories people stationed france sales nature made japan began brand continued grow offering belgium netherlands italy spain braziland portugal range highquality products designed manufactured japanese consumers pioneer one important asset ns partnerships built years local farmers nature made leads japanese supplement market multivitamin mineral supplements enabling achieve objectives sourcing main ingredients cultivated using sustainable vitamin supplements ranking instore sales respective market categories farming methods ensuring traceability today consumers governments concept nature made marked th anniversary continues recognized health shifting human health wider concept earths health quality dedication health wellness years beginning us news increased value partnerships among stakeholders continue strengthen world report survey conducted collaboration specialist publication pharmacy times asset deliver health people named nature made pharmacist recommended supplement compared precovid era percentage individuals us take supplements almost every day increased indicating awareness importance health rising accelerating toward vision nutrition sant result rising demand cagr supplement market us per year nutrition sant accelerating transformation based total us retail sales aggregate data reported scantrack service supplement vitamin category week period ended december information resources inc journeyfocusing strengthening categories intage sri multivitamin vitamin markets cumulative market share brand januarydecember brands like gerbl rapidly growing ecommerce us news world report pharmacy times survey product categories letter vitamins ae coenzyme businesswhile time simplifying portfolio q omegafish oil flax seed oil herbal supplements mood health supplements diabetic multivitamins cholesterol managementnatural garlic supplements improving operating performance order fuel growth euromonitor international uk sense aim develop strong capabilities ecommerce core countriesfrance belgium results survey frequency netherlands italy spain portugalproposing services supplement vitamin intake us yoy change nature made revenue luis uribe consumers go beyond products enable president us develop dc business also nutrition sant take less oncemonth timesmonth timesweek accelerate transformation toward vision almost everyday recommended partner natural nutritional solutions wellbeing body mind represents important shift business strategy con tinue respect foundations based nutrition local supply chain sourcing celebrate th anniversary nutrition sant reflect foundations precovid era pursuing vision lead preventive nutritional solutions precovid era dc direct consumer first halfsecond half first half second halffirst halfsecond half source euromonitor international ukcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report advancing unique total healthcare company progress three nurture brands bodymaint focusing fact athletes put bodies demanding training people lactic acid bacteria b regular stress due work study higher risk health problems otsuka lactiplantibacillus pentosus onricb plantderived pharmaceutical used research findings fields intestines nutrition exercise lactic acid bacteria isolated nutrition develop bodymaint bodymaint jelly conditioning food contains fermentation type tea leaf traditionally consumed proprietary lactic acid bacteria b well bcaa arginine whey protein main northern thailand isolated sanae okada professor emeritus ingredients support many athletes sports trainers others challenge tokyo university agriculture bodies daily bodymaint drink conditioning beverage containing lactic acid bacteria efficacy confirmed otsuka pharmaceutical b electrolytes help keep body hydrated convenient way consumers j gen appl microbiol everywhere regularly maintain health condition equelle equelle originated research conducted otsuka pharmaceuticals saga nutraceuticals equol research institute womens health research theme equelle contains equol equol ingredient produced daidzein sold japan us food product supports womens health beauty time soybean isoflavone metabolized intestinal bacteria one aspect otsuka pharmaceuticals many years aging brings physical mental changes japan deployed dedicated staff soybean research focus properties equol expert knowledge womens health nationwide cooperation physicians pharmacists saga nutraceuticals research institute succeeded isolating lactococcus strain lactic acid healthcare professionals convey importance personal care women bacteria produces equol publicize progress experiencing physical mental changes among activities aimed maintaining results variety research continue leader global research field improving health women enhancing quality life otsuka pharmaceutical also provides broad range uptodate information concerning womens health including womens healthcare project website daiya daiya foods develops manufactures sells highquality creative plantbased food products cheese alternatives dressings desserts brand daiya enjoyed vegetarians people food allergies also healthconscious millennial generation us plantbased alternatives market continues grow daiya foods expanding sales channels product lineup mainly area cheese alternatives core product third mediumterm management plan plan achieve revenue cagr contents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report advancing unique total healthcare company future nutraceutical business opportunities risks future initiatives emerging health issues utilizing expertise honed nutraceutical business involves risks stagnation pharmaceutical business otsuka group develop health awareness rise nutraceutical business global economy due covid pandemic original sciencebased products maintain improve use unique expertise accumulated intensifying competition soaring raw material shipping peoples health supply products around world pharmaceutical business provide solutions based prices shrinking market japan due population decline furthermore tenaciously continuing activities entirely new concepts address yettobeimagined needs sluggish markets due unseasonable weather despite communicate value products create entirely health issues aim extend healthy life risks otsuka group continues search solutions new product markets expectancy maintenance improvement peoples health furthermore reinforce supply chain decentralizing manufacturing sites optimizing strengths weaknesses logistics respond pandemicrelated changes creative products marketing based scientific evidence brand development field takes time consumer needs using current strategy targeting pocari sweat products longterm popularity mechanisms responding unforeseen increases demand selfmedication market countries already overseas businesses incorporate solutions social issues dependence manufacturing sites raw material suppliers business engage new types marketing activities core business processes concentrated specific regions steady earnings power major brands nurture brands improve brand w trength eakness value expand scale business accelerate global expansion new growth markets opportunities threats rising consumer awareness selfmedication prevention sluggish overall beverage market due unseasonal weather daily health tandem medical cost inflation intensification competition core areas due entry new diversification diet competitors changing consumer needs due pandemic pressure earnings due soaring raw material shipping prices pportunity supply chain disruptions due geopolitical risk hotherr efactaorstcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report advancing unique total healthcare company research development otsu nutraceuticals research institute otsu nutraceuticals research institute rd sites nutraceutical business investigating themes established advance research nutrition exercise unique viewpoints utilize expertise honed intestinal immunity particular focus pharmaceutical business intestines play key role overall health one example institutes research related saga nutraceuticals research institute enhancing bodys biological barrier addition developing new sciencebased products using inhouse research published data increasing secretion immunoglobulin continue undertake research replenishment fluids electrolytes nutrients iga antibody plays crucial role support improved physical performance conditioning among consumers mucosal immunity exploratory rd demonstrated since establishment japans first private research institute clinical exercise lactic acid bacteria b heightens nutrition saga nutraceuticals research institute conducted rd various fields related function mucosal immunity lowers probability catching common cold exercise nutrition womens health health issues one largest controlledenvironment rooms japan completed institute enabling recreation otsu skin care research institute hypoxic environments equivalent found otsu skin care research institute performs rd cosmedics wanted improve peoples altitude meters health within also without ensuring skin bodys protective previously difficult recreate well high covering cared focusing ingredient amp substance found naturally body temperaturehighhumidity low developed energy signal amp active ingredient supports skin turnover temperaturelowhumidity conditions encourages melanin excretion body ingredient main products facility helps advance research sports innersignal series ulos contains moisturizing ingredient amp based one nutrition verifying effects fluid otsukas proprietary formulas product line steadily expanded include moisturizer nutritional intake environments sunblock skin wash refresh sheets shampoo whitening care grown brand offers total skin care body head toe adenosine monophosphate denosine monophosphate moisturizing ingredient disodium adenosine monophosphate ot uppresses production melanin prevents skin blemishes frecklescontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report advancing unique total healthcare company continued activities achieve healthy lifestyles considering nutritional problems social issue otsuka group continues sponsoring tokyo marathon inaugural race supporting work create systems support peoples health range situations runners replenishing fluids electrolytes nutrients including exercise sportwhich essential health maintaining otsuka pharmaceutical official partner tokyo marathonone largest urban marathons asiasince inaugural race supported runners replenishing activities communicate importance replenishing fluids electrolytes fluids electrolytes nutrients event tokyo marathon sparked running boom since launching pocari sweat otsuka pharmaceutical continued communicate japan conjunction rising health awareness major factor increasing importance replenishing fluids electrolytes variety contexts following number domestic runners thorough infection prevention measures place establishment japan sport associations study group prevention heat disorders public able run tokyo marathon first time three years sports activities otsuka pharmaceutical began working association runners competing miles km dehydration loss energy muscle activities build understanding help prevent heat disorders ensuing years injury serious issues every year tokyo marathon replenishing fluids electrolytes company continued provide information growing number themes including nutrients runners lose major challenge finishing race safely using expertise childrens sport labor health safety rehydration senior citizens otsuka pharmaceutical business otsuka pharmaceutical provided runners evidence pharmaceuticals website includes information section titled protect heat based nutraceutical products relevant information continue offer support disorders section presenting content based japan sport associations guidebook runners future races prevention heat disorder sports activities first edition another initiative heat disorders prevention website created collaboration weather forecasters heat disorder countermeasures suited new normal japan activities interhigh school championships raising awareness topic ensuring safe operation supporting health competitors officials addition otsuka pharmaceutical factory otsuka pharmaceutical special sponsor japan interhigh school sells os oral rehydration solution provides championships eight consecutive years since due pandemic operational support oshiete kakure championships held thorough infection prevention measures place dassui iinkai organization raises otsuka pharmaceutical worked japan interhigh school sporting association awareness ways prevent treat hosting prefectures create system ensure thorough support prevention heat dehydration becomes critical disorders measures included encouraging use personal squeeze bottles athletes minimizes interaction officials prevents sharing drinks forms close contact addition supporting organizing committee members becoming qualified heat disorder prevention advisors company also worked students broadcasting team draft warning announcements regarding heat disorders ways otsuka pharmaceutical supporting athletes event staffcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report advancing unique total healthcare company consumer products others otsuka foods released bon curry worlds first commercially available food plastic otsukas diversified operations include chemical business supplies various materials pouch bags retort bags since launched range products ahead fields automobiles electrical electronic equipment building materials transportation time mannan hikari ricelike processed food made refined konjac flour warehousing business aims environmentally friendly logistics mainly otsuka group ingredients size series perfect people feel portion size calorie pharmaceuticals foods beverages electronic equipment business supports count meals high zero meat meatfree products made soybeans development leadingedge technologies otsuka chemicals operations center materials otsuka foods aims develop kinds products people happy serve friends company aims continuous technological innovation automotive electrical electronic family incorporate four key ingredients flavor safety peace mind health equipment housing healthcare areas provides products worldwide based original concepts development capabilities well traditional pioneering based organic inorganic highmolecular chemical technologies otsuka chemical engaged spirit otsuka foods continue deliver original flavors new dreams peoples tables diverse material development aim offering high added value line needs otsuka foods smart device mobility markets moreover company goes beyond offering materials propose solutions various industries global perspective otsuka chemical also succeeded development gcle proprietary pharmaceutical intermediate cephalosporin antibiotics leveraging technological expertise accumulated development process company moving forward research development active pharmaceutical ingredients intermediates including lactam antibiotics zero meat bon curry veggie zero meat developed solve bon curry veggie addition bon curry lineup range current social issues brings delicious flavors plantbased otsuka chemical india gcle production plant new office zhangjiagang otsuka chemical related health food shortages ingredients uses animalderived ingredients made environmental impact using vegetables beans produced japan bon curry otsuka warehouse provides optimal logistics solutions includes working external animalbased ingredients veggie unlike conventional curries use flourbased manufacturers promote joint distribution focus otsuka groups pharmaceuticals beverages zero meat products entirely stock instead using pureed vegetables fruits gently food products daily necessities furthermore company built itbased connected logistics plantbased using soy meat thicken sauce moreover ingredients system promoting paperless working environments ecofriendliness work style innovation alternative carefully selected ensure product veganfriendly animalbased ingredients include otsuka foods definition vegan friendly made beef pork chicken products use animalbased ingredients beef pork eggs milk honey seafood chicken eggs milk honey seafood product uses processed soybeans information httpswwwotsukafoodscojpencompanybusinessveganhtml warehouse work using digital devices paperless offices using datasharing systemscontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report message director charge sustainability treatments conditions undernutrition approach issues considering otsuka setting addressing related unmet medical needs making cohesive example pharmaceutical business seek groupwide efforts help eradicate tuberculosisone big three infectious diseases tuberculosis serious public health challenge realize sustainable society like covid accounts high number deaths every year fact tuberculosis kills million people annually particularly prevalent developing world continue work various partners around world deliver drugs address disparity access medicines due economic factors yoshiro matsuo nutraceutical business develop innovative executive deputy president director sciencebased products leverage knowhow charge otsuka group sustainability pharmaceutical business accumulated many years promotion conduct ongoing health education programs aimed tackling otsuka holdings co ltd challenges involved access nutrition see pages global tuberculosis report world health organization coronavirus covid dashboard world health organization resolving social issues business clarify groups commitment sustainable growth material issues selected consideration people quality otsuka group companies accordance social issues based characteristics strengths essential sustained corporate growth corporate philosophy otsukapeople creating new products otsuka group conducting broadranging businesses better health worldwide seeks indispensable working together achieve goals set nurturing successive generations talent essential contributor peoples health worldwide wide range material issue sustainable growth company otsuka group innovative creative products including pharmaceuticals know diversity people key innovation functional beverages foods believe making search solutions unmet needs globalization development revolutionary products philosophy reality effectively achieve sustainability always seek hire broad range people basic stance grow sustainably help one otsuka groups important missions contribute encourage effective personnel exchanges within group resolve social issues business accordance resolution unmet needs work every day help conduct training invigorates develops philosophy prevention treatment illness around world workforce otsuka group global code business ethics unveiled third mediumterm maintain improve peoples health daunting code conduct business activities global markets management plan also announced sustainability challenges remain including threat prolonged includes topics human rights diversity furthermore mission materiality initiatives otsuka focused pandemics insufficient medical infrastructure lack effective signatories united nations global compact ofcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report message director charge sustainability stipulates ten principles human rights labor strengthening group corporate issues amid rapid daytoday change external environment anticorruption well governance environment societal demands related sustainability womens empowerment principles thus opportunities participate lectures discussions underlining commitment social responsibility addition otsuka group remain relevant stakeholders outside experts latest trends also provided released otsuka group human rights policy strong governance structure necessary based realizing otsuka group committed growing engaged groupwide initiatives ensure respect corporate philosophy otsuka holdings committed sustainably accordance corporate philosophy human rights see pages maximizing corporate value sustainably medium resolving social issues business commitment quality important part long term meet commitment basic policy make otsuka spirit since companys inception quality transparent fair timely decisions fulfil corporate signifies product quality quality social responsibility living expectations stages value chain rd production stakeholders engaging ongoing dialogue governance distribution accountability customers well quality key focus since establishment otsuka sustainability management structure management continue groupwide efforts holdings continue working strengthen governance achieve higher levels quality see pages illustrated introduction enterprise risk management da elp ibp ely r af ior n otsuka holdings otsuka group sustainability promotion leader erm july see pages board directors otsuka holdings director environmental vision net zero approval sustainability management structure proposal approval promotion otsuka group aims help resolve social issues group companies otsuka group sustainability promotion committee executive charge business activities amid increasing seriousness believe sustainability initiatives integral part sustainability climate change various environmental issues business undertaken every promotion adopted environmental vision net zero employee end otsuka group established calls us reduce total environmental impacts otsuka group sustainability promotion committee examination environment procurement cr business activities zero vision identified three committee formed discuss area h ru igm hta sn cn ot ner tn roa promotion report promotion environmental material issues carbon neutrality circular determine direction plans groups sustainability economy water neutrality set new mediumterm targets efforts committee members comprise managers promotion include reducing co emissions compared departments related sustainabilityrelevant areas group companies divisions levels raised target otsuka group supply chain environment human resources general plastic policy use recycled plantderived raw affairs compliance risk management public relations activities promoted various conference bodies wgs tfs materials pet bottles group work production quality others including timelimited pj consumer relations one achieve environmental vision net zero charge supply chain environment pursuing unique initiatives realize sustainable society human rights relevant areas committee provides passed future generations see pages forum sharing initiatives progress sustainabilitycontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report health details healthrelated initiatives visit httpswwwotsukacomencsrsocietyhealthpharmaceuticalhtml pharmaceutical business challenge addressing unmet medical needs disease worldwide contribute doctors without borders programs secured funding basic policy bill melinda gates foundation development new tb treatment drugs good health universal desire otsuka group work every day help forge alliances global companies places corporate presence healthcare professionals around world prevent treat illness help ordinary aim using strengths contribute public health people maintain improve health numerous challenges remain including otsuka pharmaceutical working establish protracted infectious disease outbreaks underdeveloped medical infrastructure system sustainable drug supply appropriate insufficient effective treatment options approach issues considering prices people around world access otsuka particular focus working address unmet medical needs moreover medical costs soaring maintaining improving health delamanid need regardless issue individuals society whole face head socioeconomic conditions income level otsuka group endeavors raise awareness healthrelated issues among countries live multifaceted individuals also teams communities help people become stay approach seen use delamanid expand healthier countriesregions end section look otsuka groups initiatives targeting unmet medical needs focusing efforts eliminate tuberculosis one worlds big enough doses treat three infectious diseases cases shipped since expanding access patients worldwide battling antimicrobial resistance amr alongside hivaids malaria tuberculosis tb considered one worlds big three otsuka pharmaceutical implementing responsible access program prevent infectious diseases deadliness comparable newcomers covid outbreak delamanidresistant tb promote proper use drug ten million people affected tb year million die otsuka pharmaceutical stewardship achievements including efforts educate proper use increase contributed fight tb development delamanid tb drug global access delamanid conduct ongoing research development drug result years rd however given many worlds tb patients resistant tb acknowledged amr benchmark survey global pharmaceutical developing countriesregions africa asia parts world otsuka companies conducted access medicine foundation funded uk pharmaceutical corporate presence working expand access tb drugs dutch governments diagnostics teaming stop tb partnership organization helps developing nations purchase medicines sustainably via global drug facility details fight tuberculosis ancient disease contemporary addition work wide range stakeholders contribute peoples health face visit worldwide instance participate global health innovative technology ghit fund httpswwwotsukacomencsrsocietyhealthtohealthhtml publicprivate partnership headquartered japan aims tackle spread infectiouscontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report health nutraceutical business initiatives yettobeimagined needs provide variety information regard since held womens health seminars basic policy throughout japan furthermore launched otsuka advanced training healthy aging advance medical technology improvement public health seen supporters oathas program assist pharmacies pharmacists supporting health average lifespan increase worldwide however new health challenges also local communities program source essential knowledge community emerged declining birthdates aging populations rise lifestyle health opportunity handson practical experience measures include webpages related diseases otsuka group nutraceutical business pursues range offer insights womens health including womens health promotion project ko initiatives aimed supplying world products help people maintain improve health initiatives include development innovative products nenkilab content menopausal health issues pms laboratory combine scientific evidence pharmaceutical businesss accumulated offer daytoday health support women ages expertise ongoing health awareness programs aimed tackling challenges related access nutrition present initiatives womens health well offerings support selfmedication trend nature made supporting selfmedication trend us global leader nutrition supplements nature made developed us pharmavite founded pair pharmacists felt could done contributing total healthcare women improve peoples wellness simply prescribing drugs address issue otsuka group continues research topics relating womens health actively engage developed range products contain nutrients essential life form close product development addition equelle equelle gele contain equol possible natural state ingredient supports womens health beauty time aging brings physical mental changes otsuka pharmaceutical released tocoelle emerged rd focused premenstrual symptoms furthermore taiho pharmaceutical launched bup lady nutritional support helping families fill nutrition gaps aims improve daytoday lives women urinary urgency otsuka pharmavite based us handles group acquired uqora us provider products womens urinary health committed development sales nature made addressing health needs broad range areas contributing total healthcare women products partnered nonprofit organization feed children provide products support health three years building awareness womens health partnership company donated otsuka pharmaceutical strives support approximately million childrens chewable women leading active healthy lives multivitamins family received twoyear knows importance building supply childrens vitamins reaching understanding changing health needs families total women throughout life arming addition nature made registered dietitians individuals knowledge need provided onsite nutritional education families make choices right compensate nutritional deficiencies womens health promotion project website available japanesecontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report people details peoplerelated initiatives visit diverse human resources drive innovation httpswwwotsukacomencsrsocietypeople system generates innovation basic policy human resource development collaboration inside outside innovation always driven people otsuka group attracts talented group people offers opportunities skills development enable people make skills moreover establishing network across otsuka group views partnerships collaborative efforts inside outside group workplaces business fields actively promote communication inside opportunities help address unmet medical needs patients worldwide sharing outside group hope generate lasting source innovation expertise stateoftheart technologies boosting drug discovery capabilities free fixed ideas improving development capabilities stepping global expansion example taiho pharmaceutical established corporate venture capital cvc subsidiary us using forge network promising biotech startups human resource development academic community us elsewhere view generating innovation company also seconds employees japan cvc subsidiary years gain upholding corporate culture developing global leaders overseas experience part professional development otsuka holdings established otsuka global academy aim ongoing identification development global human resources needed sustained growth academys programs developing digitallycapable human resources target otsuka group employees worldwide designed run inhouse also partner otsuka holdings conducting variety initiatives speed digital transformation outside institutions areas effective human resource development guided throughout group one example otsuka group ai forum used share case commitment otsuka holdings executives rooted leadership otsuka groups founding studies group companies successes generally promote spread understanding figures groups unique approach business participants learn discuss kinds artificial intelligence mainly among group company presidents directors training wide people otsuka group needs next generation leaders skills expected spectrum technologies data science also provided order help boost employees possess cultivated future leadership candidates capabilities addition groupwide portal site launched disseminate meanwhile since taiho pharmaceutical partnered share inhouse external information relating digitalization outside institutions provide training emphasizes dialogue otsuka medical devices hosted training session university professors shared upholding companys longstanding corporate culture examples employ artificial intelligence field medicine meanwhile otsuka mindset inspired companys slogan acting warehouse knowing vital overcoming challenges faced logistics industry done training currently targets company executives seeking improve literacy company intends broaden coverage going forward employees inhouse study workshops encouraging employees take japanese governments highlight global elearning platform passport exam subsidizing examination april launched global elearning gel platform employing harvard fees companys commitment managementor program provided harvard business school publishing corporate learning building competency also includes first otsuka group shared learning platform group employees worldwide ongoing yearround skills training far total employees group companies countriesregions pass exam participated addition cultivating business literacy skills program features messages executives employees otsuka group ai forum top otsuka group executives well training initiatives unique otsuka group employees around globe take part together including learning caf webinarscontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report people diversity inclusion health productivity management basic policy basic policy otsuka group know contributions diverse array people otsuka group believe maintaining workplaces enable conducive innovation globalization development innovative employee work good health spirits vital making shared corporate products embrace promote diversity group companies driven philosophy reality also thinking behind declarations health made innovate committed ensuring workplaces welcoming people major otsuka group companies promotion system promotion system since diversity inclusion promotion team group company led efforts otsuka holdings executive deputy president director charge health productivity greater diversity inclusion individual company coordinated group initiatives management supervision otsuka pharmaceutical health insurance association initiatives include planning groupwide systems conducting seminars holding regular meetings group companys health productivity promotion manager specialist staff share companys effective examples diversity inclusion industrial physicians nurses work collaboratively across entire organization help maintain enhance health employees families result initiatives otsuka collaborative group activities group companies selected ministry economy trade industry certified health productivity management outstanding organizations recognition program japan introduced family smile support system encourages employees work home beforeafter parental leave taking childcare nursing care raising healthawareness among employees business activities obligations system led improvements work efficiency productivity worklife balance also introduced work interval system mandates minimum rest periods hold seminars variety topics aims deepening employees understanding shift workers also hold regular groupwide diversity seminars total people group company activities encouraging give health health attended six seminars held fiscal fiscal know enough families thought total employees attended online seminars womens employees aware issuestheir bosses must broaden awareness health cancer seminars held headaches presenteeism alcohol established ikuboss managers supportive worklife balance declaration consumption furthermore employees otsuka pharmaceutical factory produced series already led increases female manager ratio number employees taking online health support videos benefit colleagues parental leave please refer financial nonfinancial highlights highlight boosting mental physical health virtual run highlight conjunction world mental health day pocari swet run charity event took place otsuka america pharmaceutical among recipients hbas ace award october november collaboration silver ribbona mental health otsuka pharmaceutical us established otsukas network awareness npo based singapore event virtual running race utilizing smartphone app otsuka women drive efforts toward participants choose distance donate npo based far manage run diversity equity inclusion key parts global business around runners including otsuka group employees japan indonesia laced strategy membership employees running shoes took part event connects women opportunities consider succeed race participants could join online grow workplace members higher seminars hear psychiatrists athletes talk promotion rates recognition initiatives otsuka america pharmaceutical mental health focusing mental welling received advancement commitment engagement ace award exercise hydration events kind healthcare businesswomens association hba highlight otsuka work closely support consumers mental physical health award honors companies committed ensuring gender diversity leadership opportunities women part organizational dna utilizing synergy two core businessescontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report quality details quality dorelated initiatives visit httpswwwotsukacomencsrsocietyquality fields fieldspecific quality challenges basic policy help build sustainable society otsuka group guided enduring philosophy ethical considerations accordance laws guidelines customers first quality first pursues quality stages value chain research comply relevant laws guidelines striving uphold promotes initiatives taking account environment society human rights development bioethics scientifically valid methodologies viewpoints preservation environment safety management sustainable procurement cooperation suppliers share otsuka group procurement policy otsuka group sustainable procurement procurement guidelines suppliers carry robust due diligence selecting new suppliers work suppliers promote sustainable procurement regard legal compliance consideration environment human rights issues research development groupwide teamwork ensure stable supply highquality products comply relevant laws regulations administrative instructions industrial standards also working obtain international customer production certification quality food safety management standards addition service procurement quality control observe laws regulations country business patient based gxp perform quality control quality assurance utilize global safety surveillance system implement postmarketing safety measures including customer safety collection monitoring safety information concerning adverse events gxp good x practice general term good practice standards ministerial ordinances regulations guidelines established governments public institutions ensuring safety reliability building logistics foundation ultimate mission production quality ensuring supply stability msa al ks e tin nd g co cn ut sr ol man ed r sp aa ft eie tynt logistics rigorously control maintain product quality throughout pharmaceutical food product beverage distribution furthermore incorporated transportation business continuity planning including registration vehicles authorized access restricted areas emergency logistics appropriate promotion enhanced information access established code practice builds international federation pharmaceutical manufacturers associations code practice japan pharmaceutical manufacturers associations promotion code sales prescription drugs addition complying code otsuka group quality vital factory packaging manufacture marketing companies also observe industry rules guidelines provision market putting consumers position sales information prescription drugs conduct sales marketing activities responsibly high level ethics also established otsuka began manufacture sale injection drugs otsukas founder expert panel comprising members drawn multiple departments perform reviews marketing plans sales promotion materials busaburo otsuka wrote guiding principles clarify employees ensure proper manufacturing transportation sales sincere response inquiries reflection company activities today still principles display otsuka groups manufacturing sites established dedicated customer contact points staffed specially customer trained personnel field inquiries tailored characteristics facilities conveying philosophy customers first quality first service particular drugs quasidrugs food products respective products employees otsuka group remain true philosophy past opinions suggestions regarding products services proactively shared within group purpose product development improvement responsibility healthrelated company always think customers quality firstcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report quality procurement sustainable procurement cooperation suppliers sustainable procurement initiatives basic policy embedding sustainable procurement training otsuka group signatory united nations global compact ungc considers compacts positions human rights labor environment provide sustainable procurementrelated training takes consideration human rights anticorruption universal values procurement guided otsuka environment issues order embed otsuka group procurement group procurement policy sets direction consistently upholding policy otsuka group sustainable procurement guidelines throughout group moreover ungcs values maintaining sustainable procurement practices accordance specific task forces work improve skills procurement staff providing corporate philosophy otsukapeople creating new products better health opportunities learn sustainable procurement issues topics worldwide improving corporate value making contribution society briefings sustainable procurement practices target conduct briefings suppliers promotion system progress conducted briefings suppliers otsuka sustainable procurement task force supervised otsuka holdings directors hold briefings suppliers sustainable procurement practices attendees learn comprises otsuka holdings eight group companies formed task force otsuka group procurement policy otsuka group sustainable procurement guidelines meets every two months share views challenges exchange information report expectations regarding compliance events also opportunities parties stay companys progress addition formulated otsuka group sustainable procurement uptodate human rights environmental issues hear examples groups guidelines september concrete guidelines suppliers follow initiatives action suppliers agree uphold policies sign pledge affirming starting otsuka group begun focusing new areastability supply intention cooperate achieving sustainable procurement business partners addresses natural disasters geopolitical risksin addition four existing areas attention human rights labor environment anticorruption selfassessment questionnaire saq sustainable procurement target conduct saqs suppliers otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical otsuka chemical otsuka foods otsuka packaging industries otsuka techno en otsuka pharmaceutical progress conducted saqs domestic overseas suppliers suppliers sign pledge conduct selfassessment consists common saq published global compact network japan human rights saq environmental saq developed taking account characteristics otsuka group business activities based results conduct interviews suppliers seven companies interviewed fiscal interviews conducted remotely pandemic measure sharing examples sustainable procurement practices opportunities learn successful case studies cooperating address specific concerns ensures suppliers make tangible progress toward sustainable procurement group meeting sustainable procurement attendees include directors executive officers procurement staff otsuka holdings otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical otsuka chemical otsuka foodscontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report quality production quality control patientcustomer safety groupwide cooperation ensure stable supply highquality products departments japan around world ideal opportunity share learn basic policy manufacturing errors case studies company otsuka group believe providing stable supply highquality products part promotion system quality control patientcustomer safety contribution sustainable society accordingly seek make effective use characteristics businesses include pharmaceuticals foods chemical products otsuka group designs systems quality control patientcustomer safety accordance cosmedics quest level quality justifies customers faith us end characteristics business whether pharmaceuticals food chemical products believe vital pursue talent development across departmental borders maintain cosmedics comply act securing quality efficacy safety products reliable quality assurance system spanning relevant companies also advantage including pharmaceuticals medical devices observe laws regulations countries enabling us stay abreast changes operating environment minimize quality operate perform quality control based good quality practice good vigilance risks undertake dynamic initiatives contribute supply chain stability practice manufacturing sales implement postmarketing safety measures moreover otsuka groups systems production quality safety management compliant relevant laws regulations administrative instructions industry standards submit necessary reports regulatory authorities update maintain required including prescribed act securing quality efficacy safety products documentation addition regard manufacture sale pharmaceuticals otsuka including pharmaceuticals medical devices food sanitation act furthermore group companies information exchanged among general marketing compliance officer aim obtain appropriate standards certification iso quality iso quality assurance manager safety control manager established fssc food safety also foster quality culture goes beyond pharmacovigilance system facilitates constant collection assessment product safety minimum obligations required law information throughout group worldwide enabled us provide information swiftly medical institutions otsuka pharmaceutical overseas group companies established global product promotion system production quality policies implement measures ensure reliability qualityrelated data publish manuals outline common procedures strive improve quality systems instance otsuka group aim maintain stable supply highquality products end holding annual management reviewsglobally otsuka international asia arab division production departments practice stringent production management facilitates tracing japanin order promote compliance good clinical practice good vigilance products throughout entire supply chain procurement raw materials practice good manufacturing practice development commercial sale production distribution sale since product quality department pharmaceutical business nutraceutical business moreover share information hold discussions implement technical improvements group jointly hold annual global product quality meeting third meeting held online attended wide managers staff otsuka group factories around world come together approximately executives quality supervisors pharmaceuticals nutraceuticals supervision group company executives global production meeting held countriesregions including japan attendees shared information changes social years leads new activities leverage strengths otsuka group conducting landscape quality improvement initiatives addition quality performance award broadranging businesses including promotion crosscompany technical exchanges established recognize quality control initiatives efforts made train people quality terms daytoday production know importance reflecting learning control raise awareness past performance end held manufacturing errors workshops twice year since meetings bring together representatives group company production policies established pharmaceutical business nutraceutical business commitment nc global quality policy years technical exchange global otsuka pharmaceuticals quality assurance office quality production meeting headquarters inaugurated global product quality team members global production meeting returned fiscal gap otsuka group companies around world involved two years due covid pandemic meeting nutraceutical business otsuka pharmaceuticals approach quality held online theme new forms production rooted remains faithful founder busaburo otsukas words attended employees executives countries quality vital factory packaging manufacture ken konagai regions participants presented case studies including reports market putting consumers position ryo harima remote support launch new overseas plant use director key message nc global quality policy customer v di ec pe u p tr ye gsi ed ne en rt al manager big data analysis system production exchanged views qf uf aic lie yo af n ssu ut rr aa nc ce eu ticals delight quality expresses founders sentiment production headquarters joined ceremony production awards quality headquarters words declares common global commitment otsuka pharmaceutical recognize outstanding production achievements otsuka pharmaceuticalcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report quality customer service sincere response inquiries reflection company activities reflecting stakeholders views company activities basic policy recognize respecting consumer rights important human rights issue customerfacing departments otsuka group companies receive broad variety feedback declaration consumeroriented commitment made october establishes patients healthcare professionals consumers make sure feedback shared basic policies regarding commitment social responsibilities corporation appropriately relevant departments also strive share feedback throughout fulfill pursuing consumeroriented management making appropriate decisions based dialogue stakeholders value chain right executives departments properly reflected company activities value chain communication stakeholders promotion system patients crossgroup otsuka sustainable procurement otsuka group company established dedicated contact centers field inquiries consumers procurement task force communicates closely suppliers promote sustainable procurement patients healthcare professionals general consumers centers staffed trained personnel provide information appropriate inquiries reported relevant department otsuka pharmaceuticals tokushima itano factory management team company views suggestions products dre es ea lorc ph en nd production tsd u h kau foa r se ts oo ku urc se h id av e fl ao cp tom n ht ln ds oit nu lit ne e inform future improvements factory tours part community outreach customer procurement quality addition collecting feedback groupwide customer service liaison meeting service control consumerrelations office otsuka patient pharmaceutical collects analyzes consumer since held groupwide customer service liaison meeting every year customer comments social media incorporates supervision otsuka holdings directors meetings attended representatives companies safety comments product improvements pharmaceutical business nutraceutical business consumer production otsuka warehouse handles otsuka products business daily necessities ecommerce categories msa al ks e tn ind g q au na dlit py c tio en nt tr ol groups logistics operations holds meetings customer safety transport partners necessary share policies well relevant departments various companies report logistics initiatives also engages mutual customer service activities initiatives greater consumer employee exchanges aimed promoting digital logistics transformation operational improvements orientation thus fostering consumeroriented corporate culture th meeting held focused evolving consumer trends amid swift dissemination information using online sales tools enabled us provide information social changes ongoing covid pandemic best practices marketing pharmaceuticals nutritional products without product improvements informed customer feedback switching labelless bottles compromising strict covid countermeasures reflecting customer feedback groupwide initiatives leverage customer feedback high hopes deeper permeation consumer otsuka pharmaceutical quality assurance office oriented management quality headquarters consumerrelations office hold deepest respect people otsuka group annual listen customer feedback meeting years meeting work hard create sustainable society together consumers held online december connecting consumerrelations inspired ideal ethical consumption founded three key office offices tokushima osaka tokyo production plants concepts environment workers rights happiness attended representatives sales production community age longer count future toshifumi fujishita quality procurement head office departments well prof izumi kado direct extension past convinced otsuka director members otsuka holdings participants heard customer feedback department business groups consumeroriented management style imbued spirit consumerrelations office products examples feedback communication altruism defined diverse indepth ethical communication otsuka pharmaceutical shikoku university incorporated product improvements junior college stakeholders come shared widely around worldcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report environment details environmentrelated initiatives visit httpswwwotsukacomencsrenvironment toward environmental vision net zero otsuka group established environmental vision net zero aim reducing total environmental impact across business activities zero work toward mediumterm targets also advancing initiatives achieve sustainability mission overall goal carbon contribute neutrality healthier sustainable target society environmental vision reduce simultaneously net zero co emissions achieving growth compared water circular neutrality economy target target target ongoing initiatives reduce environmental impact expand plant water reduce content management program simple recycled locations globally incineration plantbased develop water use strategy landfill disposal materials business locations compared pet bottles waterstressed areas materiality material issues social issues goals activities carbon neutrality global warming target reduce co emissions compared reduce co emissions throughout value chain target r educe simple incineration landfill reduce environmental impact improving resource circular disposal compared efficiency environmental load increase economy target content recycled plantbased materials promote business activities aimed sustainability pet bottles society earth target e xpand plant water management program water reduced freshwater availability due locations globally understanding water resource risks neutrality water resource risks target evelop water use strategy business locations management effective use water resources waterstressed areas sustainable energy use sustainable use raw materials sustainable use water resourcescontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report environment otsuka group environmental management system basic policy aiming create healthy future total healthcare company otsuka group otsuka group sustainability promotion committee established environmental vision net zero aim reducing total environmental impact across business activities zero based vision determined material issues environmental sharing promotion initiatives carbon neutrality circular economy water neutrality global otsuka holdings action aimed decarbonized society gathers speed established new set executive deputy president environmental committee chairperson mediumterm targets aim proactive initiatives director otsuka holdings making decisions promote activities improve employees understanding recognition environmental strategies environmental issues environmentrelated training generate synergy among committee directors executive officers approval goals otsuka group companies act unified standpoint activity plans members otsuka group companies proposals reports approval carbon neutrality otsuka group global persons charge environmental environmental council chief officers management otsuka holdings global warming resulting change climate major impact formulation goals worlds bioresources water resources environmental problems becoming activity plans persons persons charge environmental reporting results apparent global scale group operates globally recognize climate charge management otsuka group companies activities change presents major risks time offers new business opportunities aiming contribute decarbonized sustainable society working reduce greenhouse gas ghg emissions throughout value chain line international strategy targets indicators adopted paris agreement otsuka group conducts climate change scenario analysis assess resilience strategies specifically references ieas world energy outlook materials assess business disclosure according tcfd recommendations risks opportunities c scenario c scenario october otsuka holdings announced support recommendations change global mean surface task force climaterelated financial disclosures tcfd accordingly moving temperature c scenario forward disclosure information climaterelated scenario development dependent fossil risks opportunities governance strategy risk fuels climate change measures introduced management metrics targets according r wi ase rm n g coc un e r mc e aif un ro e sa ad reit ka enl global r ni es gin ag ti vt ee imp pe ara ct tu ore ns cc ra ou ps se aa nn n locr se os fe bin io n da ivt eu rr sa itl yd isasters framework recommended tcfd c scenario scenario development sustainable governance climate change measures proactively implemented keep temperature rise c measures otsuka holdings environmental committee comprises executive deputy president director achieve decarbonized society enhanced including otsuka holdings group company directors executive officers committee responsible making r wi ase rm n g c oc u n te rmc e aif ud rr ea ss aic r eg l ab ka enl eh xe p nt sr io od nu oc ft hn e ref nc eo w ae bm lei es nio en rs g yre mgu al ra kt eio tns year decisions key challenges relating climate change furthermore resolutions matters relating groupwide direction shared company following approval board directors based ministry environments japanese translation summary policymakers working group ii report fifth assessment report published ipcc matters communicated company form otsuka group policies incorporated main scenarios referenced specific action plans board directors approved environmental vision net zero iea world energy outlook sustainable development scenario stated policy scenario aim reducing total environmental impact across business activities zero ipcc rcp rcp oecdfao agricultural outlook contents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report environment scenario analysis financial impacts responses associated risk management climaterelated risks opportunities otsuka group examines assesses climaterelated risks potential impact business financial affairs strategies otsuka holdings environmental committee considers related risks financial impacts category contents responseresilience committee members charge environmental management report matters c c deemed significant risk assessment process board directors resolutions matters policies ncreased costs due tightened approved board directors communicated company form otsuka group regulations regulations carbon pricing large large introduction internal carbon pricing policies whole group works minimize climaterelated risks introduction cofree electricity transition market steep rise renewable energy prices large large introduction solar power generation systems including mega risks steep rise energy prices large large solar power systems metrics targets improving energy efficiency energy saving fuel reputation risk investmentrelated conversion reputation risk associated inadequate response large medium investment environmental facilities japan overseas otsuka group established environmental vision net zero aim reducing total climate change water resource risks environmental impact across business activities zero addition revising co emissions r isks damage production decentralized production major products reduction target upward reduction reduction compared facilities due intensification extreme formulation disclosure sharing procurement policies weather cost increases prepare guidelines suppliers joined international initiative see next continue promote activities aimed acute extreme weather events medium large strengthening communication supply chains expanding r isks raw material procurement number suppliers subject supply chain decarbonization looking ahead maximize group synergy proactively engage efforts achieve physical disruption supply chains stable questionnaires improving enhancing contents carbon neutrality procurement questionnaires holding discussions risks ncreased energy costs associated large large systematic renewal facilities temperature rise chronic e ffects climate change drug collection information impacts drug discovery targets target reduce co emissions compared discovery using crop natural medium medium using crops natural products risk assessment products examination countermeasures fiscal ic tr e dm ui cs ts ii oo nn fr e rd eu nc et wio bs l eth er eu rg gh co emissions r efe fs ico ieu nrc ce r ine trd ou dc uti co tn io nf oo fp ee nra ert gin yg e c fo fis ct ies nth rough large medium c wo al tl ee rc ti ro en mf ein nf tr em ca ht nio lo gn tn aw dte oc eh n olo g reie qs u irs eu c sh te ae nm db rane nc ea ur tb rao ln results tco tco equipment examination introduction technologies timely manner introduction internal carbon pricing energy r toe pu roc ati co tn iv eo f ne tn roer dg uy c p tir oo nc u fe rm ene en wt ari bsk le ue large small collection information nextgeneration energy sources targets target reduce simple incineration landfill disposal compared sources energy hydrogen ammonia examination introduction target content recycled plantbased materials pet bottles sources timely manner formulation otsuka group plastic policy aims total waste volume simple incineration increased revenue increased reducing reliance fossil fuelderived materials circular fiscal landfill disposal volume oppor products demand products mitigate examination introduction recycled pet resin plantbased economy results address climate change eg products large large biopet resin pet bottle beverage containers tunities services preventing heat stroke spread examples expand sales products preventing heat stroke infectious diseases expand sales products low environmental impact throughout lifecycles targets target expand plant water management program locations globally target develop water use strategy business locations waterstressed areas increased revenue expansion development products mitigate address climate change market new market categories products medium medium address climate change eg plantbased products water usage water intensity per unit sale fiscal strengthening business continuity et nr ee rn gg yt h rn oi un gg h n p tero rnm ao l ci ao rn b n e pn icr ig ny g saving renewable new uta rt ae lr results million million resilience planning measures disaster medium large supply chain disruptions b au ns ti se es mco icn min eu ait sy u p rela n nm de mas eu sus ra et aga iu nf sa tc ft lu oin dg gi tes calculated based performance manufacturing sites consolidated otsuka group assessment businessfinancial impacts large one billion yen equivalent operating income assuming minimum operating income billion yen medium negligible less one billion yen small negligiblecontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report environment joining initiative introducing co free electricity four indonesian group companies april otsuka group joined international initiative asks companies commit using renewable energy business activities among overseas businesses highest generator co emissions japan world transitions decarbonized society environmental vision net zero indonesia engaged pharmaceutical nutraceutical chemical aim reduce total environmental impact across business activities businesses indonesia introduced cofree electricity geothermal power zero continue proactively implement measures reduce co emissions forecast reduce annual co emissions moving forward continue increasing use renewable energy maximizing energy efficiency japan around world make use group synergy contribute decarbonized sustainable society pt otsuka indonesia pt amerta indah otsuka pt widatra bhakti pt lautan otsuka chemical increasing utilization renewable energy maximizing energy efficiency otsuka group set target reducing co emissions compared achieve target increasing renewable energy usage introduction cofree electricity solar power generation equipment maximizing energy efficiency adoption cogeneration systems introduced cofree electricity manufacturing sites five otsuka group companies result reduced annual emissions approximately sukabumi factory pt amerta indah otsuka tco furthermore tokushima prefecture home many otsuka group production facilities begun upgrading cogeneration facility otsuka building new integrated energy service structure chemicals tokushima factory enable us supply electricity steam neighboring otsuka group manufacturing sites improve energy efficiency new one effort achieve environmental vision net zero reduce total cogeneration system scheduled begin operation expected cut annual environmental impact across business activities zero otsuka group established emissions approximately tco addition introduced new co new integrated energy service structure retail electricity provider model generation system changed boiler fuel otsuka pharmaceutical factorys naruto move able procure renewable energy power producers factory result annual reduction approximately tco sources efficiently supply electricity generated within otsuka group group engines turbines fuel cells cogeneration systems generate electricity natural gas lpg fuel business sites sources time systems collect waste heat thereby achieving efficient use heat electricity otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical otsuka chemical otsuka foods compared contents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report environment circular economy water neutrality line global trends us able create sustainable society achieve water resources unevenly distributed across countries regions faces sustainable corporate growth must shift sustainable business model whereby different challenges working stakeholders conduct ongoing water achieve growth without serious impact environment continue offering conservation initiatives intake discharge including cultivation water resources products contribute health people worldwide set two goals conscientious use clean return aim sustainable water use reduce simple incineration landfill disposal waste compared use revised targets include developing implementing water use strategy business recycled plantbased materials pet bottles per otsuka group sites waterstressed areas expanding plant water management program plastic policy continue increase resource efficiency throughout value chain locations globally build harmonious sustainable relationship bioresource resource sources working together group companies use world resources institutes wri aqueduct goal revised previous goal content recycled plantbased materials pet bottles water risk atlas well extensive waterrelated data assess water risks manufacturing sites within scope consolidation based assessment draw model cases water management water targets tailored country region containers packaging pet examine evaluate results launch similar initiatives sites worldwide sustainable society bottle based otsuka group plastic policy quickly moving forward measures reduce environmental processing collection aqueduct water risk atlas breakdown region water consumption pet resin otsuka group impact caused plastic containers packaging bottletobottle contributing sustainable closed loop recycling plastics resources washing crushing europe launch pet bottles made using recycled materials launched pet bottle made using recycled pet resin crystal geyser japan north april recycled pet america water stress east high asia bottle pocari sweat march high south asia moving forward n rth africa e r te high technological development sou sh ie aast mo eu rt ih ca l lo ow w oderate gradually extend use recycled use dry low water ml ml ml ml ml data pet bottles products source wri aqueduct water risk atlas crystal geyser pocari sweatcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report messages outside directors full text messages visit httpswwwotsukacomenirmanagementmessageoutsidemessagehtml unique corporate culture since founding important examine become truly global evolving corporate governance continuing reap benefits maintaining founding familys spirit otsukas development diversity unique approach biological evolution continuous process individual species within group successfully adapt yukio matsutani surrounding environment pass genes environments change always easy predict outside director otsuka holdings co ltd species able adapt given change sense believe rich diversity otsuka groups businesses enable continue evolving times hand rich diversity comes appointment present day governance structures maintaining founding certain inefficiencies aim global governance familys spirit otsukas unique approach deal inefficiencies however group must otsuka group achieved growth listing one important issues global corporate determine managed group charismatic management founding governance risk management global governance left local operating companies deal family since listing company shifted extremely complex country challenges ways markets differ country stage owneroperated company one leadership although course many issues deal development group business even business chosen shareholders structural transitions feel group steadily building organizational purposes differ overmanaging businesses also sometimes lead disruptions areas including corporate structure addressing lead inefficiencies clarifying responsibility timing governance otsukas case relatively criteria investment liquidation decisions smooth groups success respect doubt evaluating success failure particular business partly due ceo tatsuo higuchi longtime veteran progress challenges global governance important overmanagement also costly given otsuka group understanding difficulty determining keep founding familys spirit expertise global given diversity otsuka groups shareholders eliminate organizational perspective management group expands scale customers clients stakeholders essential necessary create platform decisionmaking based business growth truly global company carefully discuss best overall structure evidence data must address evolve management corporate global governance group enjoyed benefits ofcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report messages outside directors numerous personnel systems wage structures makes difficult implement shared services across companies ensure effective personnel utilization maximizing value education increase groupwide value generating sustainable roles responsibilities group company clarified important organizational growth group perspective create global personnel system strategies linked level contribution companies make group addition giving consideration ideal remuneration system could ko sekiguchi cover variety business types would enhance group governance outside director otsuka holdings co ltd responsibility contribute fulfill important role group live era continuously creating progress enhancing group governance capital cost executive director cfo yuko makino leading developing novel innovative pharmaceuticals difficult efforts addition introduction expansion important business operating addition ensuring smooth development shared services moving forward consider services company responsibly engage initiatives operating companys businesses otsuka holdings must extremely important factor enhancing group awareness contribute group manage focus maximize value ensure governance group companies differ scale structure role fulfill nutraceutical business sustainable growth group industry stage development take group stands unique unrivaled position therefore march managing director shuichi takagi considerable effort incorporate services great potential even innovation appointed cso strengthen corporate strategy nonetheless believe progress steady companies world cover everything functions otsuka holdings believe significant prevention recovery step toward enhancing group governance next step also believe need improve groupwide deepen discussion whether goal importance global personnel strategy communication strategic consideration investment operating company aligned otsuka holdings decisions strategies entrusting investment whether companies clear role addition introduction operation operating companies extensive experience perform within group keeping mind groupwide shared services global personnel functions also fulfill expertise competitive advantages specific fields synergy groups vision years key role group governance currently operating could lead even greater value important regarding finances third mediumterm company responsible formulation approach given groups aims take capital cost management plan group stated intention conduct implementation personnel systems account management business management corporatewide awareness strategies global perspective however havingcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report messages outside directors human resource development rotation allocation functions within otsuka holdings develop increase creating robust mechanisms number management personnel group companies anticipation globalization development growth nutraceutical consumer products businesses compared management foundations yoshihisa aoki pharmaceutical business nutraceutical business outside director consumer products business still otsuka holdings co ltd development stage said unique development two businesses led steady growth foundations consumer products market systems values undergoing major changes due environmental issues need address infectious diseases challenges global governance rebuilding mechanisms otsuka holdings needs factors otsuka group utilize bold investments clarify scope scale responsibility give taking changes opportunities employ management otsuka group based group company ensure groups direction unique approach believe scale business could competition among operating companies approach profitability affected otsuka holdings needs increase significantly enabled grow unique total healthcare company strengthen management capabilities world becomes complex number operating company respecting independence otsuka group companies reaches mark however time must carefully balance responsibilities founding spirit believe time reexamine groups direction control holding company responsibilities review mechanisms keeping track listed entrusts operating companies otsuka group already easy manage company maintaining faith company otsuka holdings responsibility contribute various management mechanisms place believe founding spirit however otsuka groups founding stakeholders boosting management even robust mechanisms required group spirit continues passed groups efficiency enhancing profitability consequently continues develop globalization corporate philosophy hope group make group must establish new direction rebuild number group companies continues increase although use philosophy provide even solutions mechanisms maintaining founding spirit already significant focus personnel development benefit people society appointment managing director shuichi takagi cso group stage preparations must march reflects groups intention made prepare expansion strengtheningcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report messages outside directors successes visible could inspire even successful collaborations among operating companies projects considering management topic investments whether rd expansion sales channels otsuka group policies business make much largerscale investments single entities strategies enhance group adopt larger risk appetite investments promising domains meanwhile external collaborations value otsuka group recognition gained groups comprehensive strengths much significant mayo mita possible lone operating company outside director hand group must also make correct otsuka holdings co ltd choices social demands change times therefore important create new mechanisms allow group take new challenges turn lead virtuous cycles many different businesses natural kpis differwhat important otsuka groups value organization corporate value globalization innovation synergy setting kpis management undertaken board directors constantly consider sense ownership responsibility embedding otsuka group grown huge organization management policies business strategies best improve concepts cost capital roic throughout every diverse corporate history many operating companies value otsuka group operating company group difficult task however board directors corporate governance converting indicators numerical targets way committee continue deliberate show increase decisionmaking transparency business groups true abilities maximize underlying value innovation efficiency creativity execution side governance side regarding business group make full use strong management foundation details investment priorities maximize group synergy value doubt increase otsuka groups structure enables create becoming listed company otsuka holdings date creativity operating company inspired facilitate relationships within group unlike welcomed shareholders new category stakeholder mutual improvement enabling group generate external collaborations pioneering examples include shareholders purchase shares otsuka holdings numerous innovations however current speed scale collaboration taiho pharmaceutical look forward sustainable growth change digitalization borderless information sharing otsuka pharmaceutical sale anticancer agents group communicating groups commitment external trends unprecedented amid environment us partnership otsuka medical growth category stakeholder doubt lead call even greater corporations improve devices otsuka pharmaceutical believe making improved relationships trustcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report messages outside directors meanwhile maintain better health throughout society important directly address needs patients consumers communities representative example among governance pharmaceuticals abilify maintena drug developed schizophrenia patients offers convenient otsuka always moving prescription format solutions issues face right direction society life pocari sweat another example although sales began one bottle time direct contact consumers aspiring greater heights raised awareness products advantages built popular brand almost years later otsuka developed pocari sweat ice slurry supports construction tatsuaki kitachi workers others working extremely hot conditions promoting various sites products outside director could created product development otsuka holdings co ltd marketing activities efficiency mind key mission enhancing financial efficiency governance expressed strive otsuka today otsuka group comprises companies including corporate philosophy affiliated companies conducting independent management independent company moreover otsuka groups communications often reference operating companies engaged multiple businesses otsuka groups corporate philosophy otsuka uniqueness although approach suited longterm business otsukapeople creating new products better health rather connotations specialness exclusivity management including personnel development worldwideis prime expression groups words express group willing use strong important reinforce methods tools required approach governance words better leadership take challenges others manage financial accounting managerial accounting health worldwide show groups desire ensure research development requires longterm different perspectives current environment better health governance emphasizes commitment process management supportive significant movement macroeconomic constructive approach governance words colleagues partners meanwhile large investments level essential find beneficial means looking eliminate revise creating always guarantee success rd sometimes small implementing financial management capital efficiency new products meanwhile expression groups investments lead major fascinating results even across group companies otsuka group must therefore willingness take new challenges reach greater outcome project difficult foresee incorporate approaches enhancing financial efficiency heights role outside director ensure important rd leaders commit supporting centralized capital management foreign exchange risk governance otsuka group always team also necessary create networks exchange management improving financial efficiency key group moving right direction aspiring greater information move forward gradually revising meet expectations shareholders investors heights direction projects necessary believe otsuka present significant challenge one group apply capabilities great effect group must tacklecontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report message cso sought reinforce strategic proactive approaches cooperation increasing opportunities discussion implement robust group asset strengths strategies precautionary approaches cooperation enhancing monitoring operating governance management companies quickly finding solutions emerging business ensure continue contributing challenges must also hold discussions ways create robust organization including overall lives customers direction group significance relevance business diversity value creation shuichi takagi total healthcare company otsuka groups success managing director cso chief strategy officer grounded diversity industries otsuka holdings co ltd business human resources expertise brings together furthermore operating company different stage growth one groups biggest strengths ability integrate different ideas values combining creativity operating society continues become diverse various perspectives enables respond company group governance operating environments rapidly change must take change generate entirely new value goes measures continue meet expectations business management holding company must otsuka group currently comprises companies stakeholders provide social value sense value creativity business develop opportunities date operating companies within group used imperative integrate creativity management small projects grow major successes offer accumulated creativity strengths offer unique capabilities operating companieswhich support creation new value group synergy businesses undertake independent management responsible carefully examining social needs moving forward also look promoting interaction inspiring mutual improvement generating broad identifying value createwith group among employees create new environments ranging innovation process since shift governance key enhancing effectiveness play active roles well organizational personnel holding company structure well introducing shared group management systematic overarching development programs leverage employee diversity services improved corporate functions sought perspective particular due rapid recent changes otsuka group aim continue contributing accelerate group synergy innovation end social environment need rebuild supply chain networks peoples lives total healthcare company building built mechanisms optimize asset use promote certain businesses difficult anticipate strong relationships trust enhancing cooperation collaboration example informationsharing future bring group looks grow scale within group strive ensure robust platforms operating companies shared value chains promote global development last years group governance managementcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report governance details governancerelated initiatives visit httpswwwotsukacomencsrgovernance corporate governance initiatives strengthen corporate governance remuneration institutional design corporate governance measures directors basic policy establishment otsuka holdings otsuka holdings co ltd company committed promoting sustainable term directors set one year appointment outside audit increase corporate value medium long term realizing supervisory board members begins corporate philosophy otsukapeople creating new products better health worldwide meet commitment adopts basic policy making transparent stock publicly listed december stock options performance linked remuneration introduced fair timely decisions fulfilling corporate social responsibility living expectations stakeholders including customers business partners first mediumterm management plan announced employees local communities shareholders ongoing dialogue appointment outside directors begins second mediumterm management plan announced otsuka group global code business ethics established corporate governance guidelines otsuka group global anticorruption policy established httpswwwotsukacomencsrgovernancepdfgovernanceguidelinepdf corporate governance guidelines established corporate governance report april internal whistleblowing system otsuka holdings major group companies established reporting httpswwwotsukacomjpcsrgovernancepdfgovernancereportpdf available japanese independent body outside company system granting stock effectiveness board directors evaluated options conditional progress medium corporate governance organizational structure term management plan introduced shareholders meeting corporate governance committee corporate governance guidelines revised electsdismisses electsdismisses electsdismisses established started evaluate effectiveness board directors based questionnaires completed corporate consults board directors ap cce ora ut nio tin na gl aa uu dd ii tt ss audit supervisory board directors audit supervisory board members governance recommends directors outside directors audit supervisory board started hold reporting meetings outside committee appointsdismisses mem oub te sr e e mw bh eo rm directors outside audit supervisory board members improve understanding president groups management business representative director ceo cooperates cooperates accounting audits first female directors appointed corporate governance guidelines revised instructs reports instructs reports accounting auditor internal control internal audit restricted stockbased third mediumterm management plan announced department department compensation plan introduced cooperates approval meetings prior otsuka group global policy conflict interest material matters groups boards consultation established management corporate ex post guidance auditors facto reports accounting auditors changed corporate governance guidelines revised subsidiaries shareholders meeting board directors audit supervisory board members etc otsuka group global antifraud policy formulated ratio independent outside directors otsuka group global speakup policy formulated increased one thirdcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report governance board directors director skill matrix line board director regulations board directors convenes regularly technology strategic legal healthcare major global planning finance compliance company rd administration qualifications month holds extraordinary meetings necessary make important business business production marketing accounting risk analysis public health etc sales management decisions supervise execution operations ichiro otsuka term directors otsuka holdings set one year clarify executive responsibility fiscal year furthermore company works ensure overall tatsuo higuchi diversity directors appoints people insight expertise experience needed yoshiro matsuo realize maintain appropriate effective corporate governance internal yuko makino directors comprehensively evaluate experience expertise insight attributes shuichi takagi candidates ensure qualities needed implement groups masayuki kobayashi corporate philosophy code business ethics management strategies outside directors company looks individuals wealth knowledge extensive noriko tojo experience various fields company requires candidates ability makoto inoue adequately exercise management oversight functions fair objective monitoring yukio matsutani md supervision auditing management neutral objective viewpoint ko sekiguchi meetings held fiscal average attendance yoshihisa aoki mayo mita ratio independent directors ratio female directors tatsuaki kitachi cpa outside directors female directors inside directors male directors director selection criteriaindependence standards outside directors httpswwwotsukacomencsrgovernancegovernancesystemhtml reasons nominating director refer notice calling th annual shareholders meeting httpswwwotsukacomenirstockpdfmeetingpdf contents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report governance evaluation effectiveness board directors major matters deliberated board directors category major reports discussions fiscal january february company conducted questionnaire survey directors audit supervisory board members results survey reviewed monitoring progress consolidated results plan business performance discussions current conditions issues regarding performance company attorney considered evaluated board directors meeting plan operating company business segment march monitoring progress mediumterm management plan questionnaire items follows identification issues improving effectiveness board directors composition board directors approval officer election remuneration directors understanding knowledge business fields specific management corporate governance monitoring subsidiary activities strategies plans confirmation progress measures reinforce group governance review crossshareholdings cooperation outside directors cooperation audit supervisory board formulation group energy strategies approval support recommendations task force climate operation board directors meetings related financial disclosures tcfd governancerelated matters confirmation status execution programs cultivating management sustainability personnel function board directors determining direction management strategy formulation environment vision net zero approval revised ii monitoring business respect execution management strategy material issues approval joining international initiative iii understanding perspectives major investors stakeholders iv risk management discussion license agreement joint development commercialization otsuka pharmaceutical sumitomo dainippon pharma sumitomo v cooperation information sharing operating company partnerships pharma us subsidiary sunovion pharmaceuticals support system outside directors discussion pharmavites acquisition uqora operation corporate governance committee meetings frequency agenda etc approval internal control reports update implementation global training overall functioning board directors perspective effectiveness programs confirmation conflicts interest approval activity reports activity plans annual reporting internal whistleblowing system whistleblowing system risk management improvement status number reports overview approval action plan summary evaluation fiscal formulation new global policies otsuka group human rights policy otsuka group global antifraud policy otsuka group global speakup policy overall opinion improvements made previous year reporting erm monitoring activities board directors functioning appropriately standpoint effectiveness reporting progress initiatives reinforce overseas crisis management nonetheless results confirmed need ongoing efforts make improvements areas role company holding company approaches fully formulation funding policy coordinating sharing information subsidiaries stance company financial strategy discussions new capital investments respect investors stakeholders formulation dividend policy reinforcement cyber security measures reporting otsuka group activities etccontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report governance corporate governance committee ratio independent major matters deliberation outside directors otsuka holdings established corporate governance committee february outside directors nomination director audit supervisory board member advisory body board directors committee discusses matters relating inside directors nomination succession plans enhancement corporate governance structure including nomination directors audit supervisory board members well succession plans remuneration remuneration remuneration systems levels directors audit supervisory board members system remuneration levels directors audit supervisory board members reports results deliberations board directors committee seven corporate improvement group governance global members president director charge administration outside directors five governance matters g po rov mer ta ion nce e tcr ganizational structure innovation publication report president serves chair committee effectiveness corporate governance committee audit supervisory board initial role corporate governance committee nomination remuneration committee although committee continues effectively carry role allocates ratio outside audit supervisory board members attend express time discussion corporate governance overall greater freedom board audit supervisory directors feel committee evolved point discussions get opinions meetings board directors monitor board members roots corporate governance performance duties directors terms legal outside members yukio matsutani outside director compliance soundness management audits inside members ensure effectiveness auditing audit although president serves chair committee corporate governance committee meetings become platform truly open discussions currently issues supervisory board members systems established regarding transparency considering discussions sustainabilityrelated matters increase audit supervisory board members interview even may best set separate committee matters concerning nomination directors employees status business remuneration governance execution review internal consultation documents ko sekiguchi outside director important documents pertaining business execution current structure enables lively exchange opinions believe committee serving promptly receive reports execution operations purpose effectively look forward even indepth exchange opinions future requested statutory auditors office yoshihisa aoki outside director established assist duties audit supervisory board committee provides outside directors opportunity exchange opinions members convenes meetings audit supervisory interact individuals execute business operating company financial board assists duties audit supervisory board market attention succession plans increases grateful get firsthand look different kinds leaders various group businesses approaches leaders members independent directors authority take toward management operating companies mayo mita outside directorcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report governance audit supervisory board member skill matrix remuneration directors audit supervisory board members strategic legal basic approach officer remuneration technology healthcare major global planning finance compliance company business rd marketing accounting risk analysis administration qualifications companys remuneration plan directors audit supervisory board members production public health etc sales management designed achieve sustainable growth enhanced corporate value medium yozo toba long term group based corporate philosophy also ensuring functions business execution management supervision exercised hiroshi sugawara cpa appropriately maintaining transparency fairness kanako osawa attorney remuneration levels sachie tsuji cpa considering need acquire motivate outstanding personnel take responsibility companys global business activities company sets remuneration internal audit department levels fully commensurate roles responsibilities expected personnel companys internal audit department reports directly president department also considering levels companies company considers benchmarks based scale industry business model regularly conducts audits based internal audit rules verify operations executed appropriately efficiently regard assets business remuneration system company affiliated companies department submits audit reports regard remuneration directors responsible business execution company president directors audit supervisory board members need formulated remuneration system closely linked performance individual improvement department recommends remedial actions later confirms fiscal years well medium long term emphasizing sustainable implementation thereby contributing optimization business execution enhancement corporate value remuneration consists fixed remuneration basic remuneration performancelinked bonuses sharebased payments emphasizing link internal control department shareholder value remuneration outside directors audit supervisory board members comprises fixed remuneration basic remuneration light duties company views internal controls integral component corporate governance functions together compliance risk management established internal total remuneration directors audit supervisory board members control department department charge compliance risk management total amount total amount type remuneration million number improve internal control system internal control department promotes otsuka remuneration eligible fixed performance sharebased group global code business ethics otsuka group global rules otsuka million remuneration linked bonus payment officers holdings affiliated companies also works establish promote compliance directors programs risk management programs company status establishment outside directors operation programs regularly reported board directors audit supervisory board accounting auditor audit supervisory board members outside audit internal control department handles internal controls regarding financial reporting supervisory board members company affiliated companies department formulates rules manuals total pertaining internal controls provides training ensures employees thoroughly outside directors understand operational rules department also works cooperation internal outside audit supervisory board members audit department continuously monitor status operations basis notes directors company concurrently serve employees internal control system management personnel reliably evaluated fiscal outside directors audit supervisory board members received total remuneration million companys subsidiaries services directors audit supervisory board memberscontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report governance content remuneration directors excluding outside directors fiscal year evaluation allotment ratio summary release conditions content remuneration directors excluding outside directors follows allocation timing remuneration type pa fy ixm ee dn vt rie bh leod including policy deter mm inu ne gr ta mio inn g c r ce nt ditions remuneration ie nr ci ue ms b ency st df rth e fisll co ac l yt ee ad r e aa sc th h ey e ea vr lt ua ak ti og n p esi rn iog dle hun ob wjc eo ecn vt ed f ri ti c ho en l syo hef aa rrn e sc su winm ilg lb l nee n f ti c bsy c e ai n rl e yt leeh aae sr e number combined consolidated revenue remuneration directors holding company determined based duties condition shares consolidated operating profit target responsibilities including formulation group strategies monitoring group achievement rate less operations strengthening corporate governance evaluation period three fiscal evaluation period value remuneration directors serve concurrently directors subsidiaries years fiscal fiscal may fall value fixed cash operating companies determined based duties responsibilities including series b shares three cumulative amount planned remuneration fixed e fox mcu ut li ao tn io nf ob fu ss ti rn ae tess g ib ea ss fe od r p eg rr ao tu inp g ctr oa mte pg aie ns ie f r nu dl st te red n b gy th ents iu nk ga c h oro pld oi rn ag tes ec dh ii uev tee rn mt ns uta mn bd ea rr f ehe aa lr us aaa trl il oo noc fa p ee h rd e io p dt e rh ie sd ts ha em te w oim fe ca l v b e el fu de r iu eo f r tc eo r n mes x p ml eid na st e ae gd e mb ou f e ni hn te e p las h np ir r fit governance remuneration shall exceed upper limit remuneration resolved performance shares years fiscal fiscal cumulative amount actual value shareholders meeting targets shares two consolidated business profit fixed remuneration paid equally every month ea r ss aa rll oc fa te hd e pt e rh ioe time rd expenses evaluation period remuneration paid lump sum certain time every fiscal year amount evaluation period three fiscal evaluation period value calculation method determined based rate achievement fiscal years years fiscal fiscal may fall value performance cash targets consolidated revenue consolidated operating profit consolidated business series c shares three cumulative amount linked bonus variable p coro nf si ot lb ide afo ter de r p erd fo e rmxp ae nn cs ee r g e p tsr ag nre ds w ait ph p r os pp iac tt e b um sie nd ei su sm mt ao n alo gn eg mt ee nrm n ts ha et msf ea dct iuio mn ef r ns uta mn bd ea rr f ehe aa lr us aaa trl il oo noc fa p ee h rd e io p dt e rh ie sd ts ha em te w oim fe ca l cn ac pan ic tcs aoo l rl ci dd oaa sn tt e c rd e wc ioo ts fht ro hf hec e c p ei vnt aa lol u l idc ta ia ol tc neu pla et id compliance corporate governance along individuals personal performance cost capital shares years fiscal fiscal cumulative amount actual condition shares two value consolidated net operating company introduced sharebased payment plan reflects progress years allocated time profit tax evaluation period achieving targets third mediumterm management plan covering period start period fiscal fiscal note restricted stock allocation agreements concluded grantees stipulate certain cases transfer restrictions plan restricted stock allocation agreements stipulating conditions including restricted stock shall released company shall acquire restricted stock without paying compensation noncash transfer restrictions set period concluded grantees plan designed example sharebased restricted function effective remuneration system combining multiple release conditions director company retires end transfer restriction period company shall acquire without paying payment stock transfer restrictions including set performance evaluation period performance compensation directors restricted stock upon retirement director except company recognizes variable achievement principle granting restricted stock requiring evaluation reason completion term office death performance several fiscal years time first fiscal year director retires end transfer restriction period due reason completion term office specifically stock granted fiscal year items requiring evaluation performance death number shares restricted stock released timing release shall reasonably adjusted necessary company shall acquire without paying compensation shares decided transfer restriction single fiscal year time first fiscal year evaluation period released items requiring evaluation performance several fiscal years performancebased release conditions met company shall acquire without paying compensation shares decided transfer restriction released overview noncash remuneration restricted stock determine number shares allocated grantees restricted stock standard number shares set fiscal year individual giving consideration performance duties responsibilities weighting versus fixed remuneration basic remuneration based standard number shares shares allotted series fiscal year time first fiscal year evaluation period several fiscal composition outside director remuneration years according specified release conditions remuneration outside directors comprises fixed remuneration variable components based business performance details latest information corporate governance officer remuneration visit composition audit supervisory board member remuneration sustainability section otsuka holdings website httpswwwotsukacomencsrgovernanceofficercompensationhtml remuneration audit supervisory board members comprises fixed remuneration alternatively please refer th annual securities report variable components based business performance httpswwwotsukacomjpirlibrarysecuritieshtml available japanesecontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report directors audit supervisory board members march directors ichiro tatsuo yoshiro shuichi yuko otsuka higuchi matsuo takagi makino c r dh e irpa ei r cr e tm oea rnn aa tn ivd e p r dr e ie rp es ri ced ts oe en rn ct en oid v e e p dx r ie esc cu tt oeiv n ad ne dp u ty csa onaging director e cx fe ocutive director profile profile profile profile profile apr joined otsuka pharmaceutical factory inc mar joined otsuka pharmaceutical co ltd apr joined otsuka pharmaceutical co ltd apr joined tobishima corporation apr joined otsuka pharmaceutical co ltd jun executive director director consumer products development jun senior managing director otsuka pharmaceutical co ltd pharmavite jan vice president associate general manager general affairs sep joined otsuka pharmaceutical co ltd apr joined baxter limited division otsuka pharmaceutical co ltd nov executive deputy president executive director otsuka pharmaceutical department otsuka pharmaceutical co ltd aug finance department oiaa division otsuka pharmaceutical co ltd apr joined otsuka pharmaceutical co ltd jun managing director responsible consumer products publicity co ltd jun vice president general manager general affairs department jul corporate finance accounting department otsuka pharmaceutical mar director corporate finance accounting department promotion development division otsuka pharmaceutical co ltd jun executive director responsible us business otsuka pharmaceutical otsuka pharmaceutical co ltd co ltd otsuka holdings co ltd dec executive director research development otsuka pharmaceutical co ltd nov senior vice president general manager general affairs mar vice president responsible india business otsuka pharmaceutical sep vice president director corporate finance accounting factory inc jun president representative director otsuka pharmaceutical co ltd department additional responsibility legal affairs external factory inc department otsuka holdings co ltd may representative director otsuka pharmaceutical factory inc jun executive director otsuka pharmaceutical co ltd relations otsuka pharmaceutical co ltd may ceo claris otsuka private limited otsuka pharmaceutical india vice president director accounting department otsuka pharmaceutical dec executive deputy president representative director otsuka jul president representative director ceo otsuka holdings co ltd jul managing director corporate administration otsuka holdings co ltd private limited co ltd pharmaceutical factory inc current mar senior managing director corporate administration otsuka holdings jan senior vice president presidents office otsuka holdings co ltd apr vice president director tax department otsuka holdings co ltd j j ju u ue l n nc p e e rxxr ee ee ps cc ri uud ett se ii v en v e nt e td adn e ti pd ir u er c yte p p irr r r e eeos cse tt osn eu rt na k ott av th sne u dod k l ed air xi e n pec g c ht uo r ric v mo e ds c u l ertk e uda c cop arh la fr cua tk oc ae r yu h oi ic nla cl n f vga isc c eco lin tdc f mee abc r e p c cx r h uee rsc riiu r ed nt ei tv n e nt ad ani nr de c r rt eo epr p r ro e est ses eu n nk taa tic iv veh e e dm ir ri ec eca ctl oc r r tl sut ud k k p ph ha ar rm ac ce eu ut ti ic ca al l c co l lt td j man ar r c e eex xo e en c ci ou ul rt imv v e ea dnai er g pe uc nt tgo r p ri ert e ss c iu dtk ea r n tom ate nsd u di k c raa e l h pd eldv sei ic n ne g ts tc c ivo e l lt rd e c tc ou rr r oen tst u ka mar e e cx x ote es uc c u u lk tt ta di v v pe eh dari ir rme ec cat tco oer ru tf bii c un sa l n ncc eoe pln od r tb fou ls ioin e ms np ao grt ef mol eio n tm oan tsa ug ke lt ings ar r v e ex xi tc e ese u c c u ukp tar ie v vps e ehi dae r r rm e et c c td c oei r rr u e c cc ic fto orplr c oo orof sth uele kt f adf hn aa onn lc dc e ie n g st sa cuc okc ao u lh tn dt l n ig cn u gd rs ecp na tr lte dn chairman representative director otsuka holdings co ltd pharmaceutical co ltd current oct president otsuka america inc current mar executive director finance otsuka pharmaceutical co ltd current mar executive director otsuka pharmaceutical co ltd current executive deputy president director otsuka holdings co ltd current mar managing director business strategy otsuka pharmaceutical co ltd chairman otsuka pharmaceutical factory inc current chairman representative director otsuka holdings co ltd current managing director cso otsuka holdings co ltd current mar representative director otsuka pharmaceutical factory inc current masayuki noriko makoto kobayashi tojo inoue executive director executive director executive director profile profile profile apr joined daiwa bank ltd resona bank limited apr joined goldman sachs japan corporation apr joined otsuka pharmaceutical co ltd oct joined taiho pharmaceutical co ltd aug joined shearson lehman brothers holdings inc jun vice president general manager diagnostic division otsuka aug president taiho pharma usa inc taiho oncology inc jul engagement manager mckinsey company japan office pharmaceutical co ltd sep executive director taiho pharmaceutical co ltd jun director intel capital japan intel corporation jun senior vice president deputy general manager pharmaceutical business division otsuka pharmaceutical co ltd apr president ceo otsuka america inc aug managing director corporate development otsuka holdings co ltd mar executive director executive vice president general manager apr president representative director taiho pharmaceutical co ltd feb executive director otsuka medical devices co ltd nutraceuticals business division otsuka pharmaceutical co ltd apr e cc x hu e ar cr iue rmn tit v e n ti ihc oto nt ca oih loo g p yh ia nr cm c u urs ra en ti nc ap ur g p exre es ci ud te ivn et dn ird e cc te oo r dts cuk ea pm ar ri mca v tec llc mp ar r e mx ae ncu agti iv ne g dir ie rec cto tor r p nh ua tr rm aca ev uit te ic l al lsc business otsuka pharmaceutical jan president representative director otsuka medical devices co ltd co ltd mar executive director otsuka holdings co ltd current current sep executive director daiya foods inc may executive director otsuka america inc mar senior managing director nutraceuticals business otsuka pharmaceutical aug chairman pharmavite llc co ltd mar executive director otsuka holdings co ltd current oct chairman nardobel sas mar executive deputy president executive director otsuka pharmaceutical co ltd mar president representative director otsuka pharmaceutical co ltd current executive director otsuka holdings co ltd currentcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report directors audit supervisory board members outside directors yukio ko yoshihisa mayo tatsuaki matsutani sekiguchi aoki mita kitachi outside director outside director outside director outside director outside director profile profile profile profile profile apr intern pediatric department st lukes international hospital apr joined mitsubishi corporation apr joined itochu corporation apr joined morgan stanley japan securities co ltd mitsubishi ufj oct joined sanwa tokyo marunouchi office audit corporation deloitte oct joined ministry health welfare ministry health labour may joined boston consulting group jun executive officer itochu corporation morgan stanley securities co ltd touche tohmatsu llc welfare jan general manager sterrad business division johnson johnson apr managing executive officer president food company itochu jan equity research division healthcare morgan stanley japan securities apr registered certified public accountant aug directorgeneral health policy bureau ministry health labour medical k k johnson johnson k k medical company corporation co ltd jul partner tohmatsu co deloitte touche tohmatsu llc welfare nov president representative director janssen kyowa co ltd apr member board senior managing executive officer president dec managing director morgan stanley japan securities co ltd apr commissioner public interest corporation commission cabinet office aug director national sanatorium tama zenshoen janssen pharmaceutical kk food company itochu corporation dec senior advisor investment banking business unit healthcare oct leader advisory development division deloitte touche tohmatsu llc apr president national institute public health jul chairman director janssen kyowa co ltd mar administrative officer itochu corporation current mitsubishi ufj morgan stanley securities co ltd nov member board deloitte touche tohmatsu llc dec vice president international university health welfare oct supreme advisor janssen kyowa co ltd jun outside director arata corporation current mar outside director otsuka holdings co ltd current jun leader industry service division advisory service headquarters mar outside director otsuka holdings co ltd current jan representative director dia japan sh dia japan mar outside director otsuka holdings co ltd current deloitte touche tohmatsu llc jun president japan public health association current apr outside director nic corporation solasto corporation jun thought leader deloitte tohmatsu llc mar outside director kenedix inc sep special adviser governor kanagawa prefecture current mar outside director otsuka holdings co ltd current mar outside director otsuka holdings co ltd current audit supervisory board members yozo hiroshi kanako sachie tsuji toba sugawara osawa outside audit standing audit outside audit outside audit supervisory board supervisory board supervisory board supervisory board member member member member profile profile profile profile apr joined otsuka chemical holdings co ltd otsuka chemical co ltd oct joined chuo audit corporation apr registered attorney law daiichi tokyo bar associationjoined oct joined tohmatsu co deloitte touche tohmatsu llc jan director information center otsuka chemical holdings co ltd oct joined deloitte touche tohmatsu deloitte touche tohmatsu llc kajitani law offices current apr registered certified public accountant jan cfo trocellen gmbh apr registered certified public accountant oct admitted bar state new york jul representative director splus corporation bizsuppli may operating officer information system department otsuka chemical feb vice president capital management co ltd current jun outside director audit supervisory committee member lintec corporation current holdings co ltd otsuka chemical co ltd jun outside audit supervisory board member otsuka holdings co ltd corporation current jun director association certified fraud examiners current jun corporate officer director corporate finance accounting current apr committee member reform collateral law legislative council mar outside director audit supervisory board member sbs holdings department otsuka holdings co ltd jun outside audit supervisory board member otsuka pharmaceutical ministry justice current inc current dec executive director corporate administration accounting otsuka co ltd may director japanese association business recovery current jun outside audit supervisory board member shindengen electric chemical co ltd oct outside director nippon parking development co ltd jun external director tpr co ltd current manufacturing co ltd current mar executive vice president corporate finance accounting mar audit supervisory board member otsuka pharmaceutical co ltd mar outside audit supervisory board member otsuka holdings co ltd mar outside audit supervisory board member otsuka holdings co ltd corporate service department otsuka holdings co ltd current current current mar standing audit supervisory board member otsuka holdings co ltd current mar audit supervisory board member otsuka chemical co ltd currentcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report governance awareness surveys measures trainees required submit signed declaration compliance observe regulations results training status submission declaration forms regularly reported meetings board directors operational status internal reporting systems internal audits group companies likewise reported examples initiatives include basic policy appointment compliance officers overseas group companies regular meetings sharing otsuka group seeks earn trust stakeholders achieve status progress country asia instance director charge compliance visits sustained growth contributing peoples health worldwide acting companies gather information offer suggestions improvements made good faith highest level ethics accordance corporate philosophy otsukapeople creating new products better compliance promotion system health worldwide commitment encapsulated otsuka group global code business ethics outlines standards behavior board directors expected everyone involved work reinforced range supervises reports global policies reflect behavioral standards core areas regular training helps ensure compliance stance thoroughly embedded risk management committee administered otsuka holdings details various global policies compliancerelated internal control department initiatives visit website httpswwwotsukacomencsrgovernancecompliancehtml instructs reports group companies departments charge compliance compliance promotion system holding company whose role maximize groups corporate value otsuka holdings monitoring system established system appropriate business operations perspective group whole companys internal audit department reports directly president department conducts established system facilitating cooperation otsuka group system group regular audits based internal audit rules verify operations executed appropriately companies report otsuka holdings necessary regarding items specified affiliated company efficiently regard assets business general otsuka holdings otsuka group management regulations obtain approval relevant important items board directors companies audit reports submitted president directors audit supervisory board built groupwide risk management system includes establishment risk management members need improvement department recommends remedial actions later committee chaired president representative director oversees systems operation confirms implementation thereby contributing optimization business execution risk management committee board directors receive regular reports compliance department also shares information works cooperation audit supervisory board members risk management action plans results internal control department reports accounting auditor plans form basis discussion issues additional measures otsuka group operates crisis management system enables swift cohesive response instill thorough compliance group companies otsuka group conducts universal training risk event demanding urgent response occurs outside japan critical timesensitive based policies otsuka group global code business ethics otsuka group global event occur group company immediately shares information main operating anticorruption policy otsuka group global policy conflict interest training materials companies otsuka holdings relevant departments mount coordinated response available english french chinese korean indonesian languages distributed group mitigate impact otsuka holdings maintains updates regulations manuals documentation companies executives employees attend related training least annually depth setting fundamental approaches risk management response enhances groupwide breadth compliance understanding among employees evaluated test training readiness regular training exercisescontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report governance governance tax compliance work maintain improve taxrelated governance recognizing contributes enhancement corporate value end strengthening cooperation operating companies well securing training capable human resources thereby maintaining appropriate basic policy system enhances groups tax compliance reduces tax risks furthermore established otsuka group operates around world recognizes reporting obligations board directors audit supervisory board regarding appropriate payment taxes accordance relevant laws mentioned policies processes well ongoing implementation maintenance regulations country region contributes local economy countries regions group complies otsuka group global code business ethics groups tax policy countryspecific laws risk management regulations tax treaties well international taxation rules engage transactions designed evade payment taxes carries appropriate filing payment taxes country endeavor appropriately disclose information ensure degree basic policy transparency trust dealing tax authorities country otsuka group recognizes pursuing management efficiency globalization business makes tax oversight complex controlling risks inherent business activities important enhancing continuously updating information consulting tax experts corporate value end vital establish groupwide system necessary appropriately responding order minimize tax risk enables executives employees uncover identify deal risks related work swiftly otsuka group manages risk via initiatives outlined supervision top management correspondence tax authorities otsuka group remains committed building constructive relationships tax authorities countries regions operates economies become global digital organization economic cooperation development oecd organizations reviewing risk management system basic rules international taxation shift toward system even enterprises without permanent enhance risk management otsuka holdings main operating companies facilities location liable tax income earned market means process reporting company introduced enterprise risk management erm july purpose recognizing local tax authorities become complex farreaching continue improve assessing groupwide risks prioritizing allocation resources control significant risks reliability tax data establish systems provide promptly part erm define uncertainties could major impact ability fulfill corporate philosophy achieve business strategy goals risks established groupwide transfer pricing policy risk management framework system risk assessment effectively efficiently manage otsuka group calculates transfer prices based oecd guidelines created significant risks faced group framework system perform risk assessments prevention double taxation fair application transfer price tax system well identify gauge significant risks faced groups main operating companies determine countrys transfer price tax system makes efforts ensure proper transactions related whether mitigate transfer avoid accept risks develop implement risk management policies parties also necessary make use advance pricing agreements apas obtain aheadof conduct monitoring activities ongoing basis time consensus tax authoritiesgovernance otsuka holdings risk management committee oversees groups erm whole committee participates deliberations significant risks reports meetings board directors formulates monitors implementation policies management significant risks provides instructions support main operating companies needed board directors receives reports committee activities issues instructions necessary oversees efficacy groups erm structure details risk management activities risk management system identification significant risks begins sharing risk awareness senior management interviews otsuka holdings main operating companies topdown approach well board directors assessments risks controls frontline employees bottomup approach enables us comprehensively identify risks exist group group company develops risk reporting supervision risk management instructions risk management policies risk management action plans risks judged significant activities management activities risks regularly monitors reviews status risks progress action plans risk management committee otsuka holdings aggregates visualizes significant risks faced group company chair president representative director grasp comprehensive understanding existing risks status controls group decisions status risk management common risks apply whole group studied closely significant risks gathered rr ie skp mr ati nn ag g en et na ttus monitoring status risk management identified based results process risk management committee assigns priority review risk management system significant risks could major impact groups business financial losses coordination companys risk management business continuity pdca initiatives visualization group risks identification risk map otsuka holdings groups significant risks risk categories degree impact level control plan check action awareness management review risk risks management status cot miu n pk oa nph ie eo r sl ad ti ng gs awareness r cd se mkhn si pt g ai afi h nc e e ya att co hn f p ao cof tr lr im ocs nku eg l pea lat ai ne dn n r r p pic lsi k lk ni v cm sm ei sea n sn aa nb gg da ee aem cd e te n io tn nt pv e rao oa vnn gl iu eai rt wa ego se r sao mi n n eg f n aa rf e cn tr pd n ii os dk nri tc sia nt go r os n workplace risk reassessment risks tcapmi fo eerged puorg elohw eht contents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report otsuka holdings main operating companies develop implement countermeasures significant risk based characteristics risk tolerance otsuka holdings provides necessary guidance support group companies submit reports seek advice otsuka holdings appropriate activities whole group coordinates closely promote practice erm moreover otsuka holdings group companies work prevent risks realizing regularly monitoring confirming within respective tolerance levels major risks requiring risks requiring prioritized regular groupwide strengthening monitoring groupwide control risks risks certain level additional action plans control implemented achieved operating companies minor level risk high control lowcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report governance significant risks details business risks visit website groupwide risk assessments otsuka group recognizes following significant risks httpswwwotsukacomenirmanagementriskhtml otsuka holdings main operating companies taking steps mitigate item risk scenarios response risk management policies pharmaceutical business healthcare revision drug price standards lowering drug prices om nio tn os rt inra gt ng ah ne v la yzlu ine g af dn mew id str ru ag ts va en td r ep nr sviding products appropriate prices c core pti ng v wa hlu ile e ms aa nto tata inl ih ne ga alt h hc ea ar le th risk cost containment measures encouragement use generic drugs biosimilars creating value total healthcare company appetite delay cancellation rd enhancing pipeline priority areas op fh na erm w dc uu gt dca el v eb lu os pin ess n uncertainty reduction exclusive license periods expanding range development items e hv ee al lo tp hi yn rg n ke aw p pd er tu ig tes maintaining significant emergence competing products proper portfolio management appropriate review rd policy bri usk sis n en sc ore pharmaceutical business side effects suspension sales recalls due serious side effects e es st ta ab bl li sh hi ng g sa ysf te et foa rn ia mg pe lm emen et n tt ir nu gc su ar fe e yin mcl eu ad si un rg e c inll e ac ct cio rd nd ce e wva il tu ha tt hio en r eo gf usa laf te oy n sn ofo f r em aca hti con untry region r ad nu ac gin eg r ei nsk b sty r ust cr te un regthening safety areas inn tu ot r na ec weu ct aic ta el g b ou ris ein e ns e rx ep ga ion nsi son f c da h ei tlu enr rge ioe rs f top io r ao nnd odu f c ett rs ce ot ng oa md hd e icnr e cin oss g n c dou ts l oo e nm g sa e l pr r e lse te r id cc li inn ss tability repo lt en vmit ao nzr tii n n dgg e pa ra rd tt mea gn eya n l tfy srz cin og pm eloa rancr tgo ta gen r omd n p eei fc frr eso p c tet ir vce ein v id nes fb oa rmse ad io n p cr oo lld eu cc tit nn ad n l c aa nl ac lh ya sir sa c ne dri st ti rc tegizing c r ae pr ge pa eot tni tsg e w v ha il lu ee ne taw c ia nt ge g ao hr eie l ta hn yd r isk p qn r uou adt lr iu ta ycc te su bt uic sa inl eb su ss n foe oss sn ad fe c n nu dm er q cau ua sl eit dy bp yr qb ul ae lm itys ce ng r oco l sn yt sa tm emin fati io lun r eby hazardous substance e c nqs gu u ii nitg gio c qno u lp id tl yi mac ie pn rw oe vi nt eh nle c eeg n sl f c hn e rd r ot ur ife gig c hau al ia uot dno isr sa n r ee tq ciu ni tr ee rm nae tn os n aa ln sd ag dv ae rr dn smental industry standards r r se ae l fd eu te yc sg ur qi rs auk na b cli ey ys mre ng gh ee mni en ng ay nst de ms cua nl lde tu n u rt n e r e aec nrr dsu ct onm rd pe ont rg tn efd c p od hre ip lv ooe srl oo ptp e hm yent f fsta ari ial lu uter eg yt de ec vu er le psu tf af li eci ne tnt human resources execute highlevel pd mti tic ina gti dn iv en rsd e bv ae sl eo dp one n tht eo f f tu sutu kr ae gg ue pr gt li oo bn lo cf om da en oa fg um se inn et h u em tha icn r ae nso du prc os v iv dia g rs eu lk ea va g nl sb ya sl ea mca ae nm mechanisms r ree sd ou uc ri cn eg r eis vk e lb oy p mtr ee nn tg gth roe un pin wg ih du eman building structure eg establishing committees addressing environmental issues pre ola le mn saction responses regarding resolution environmental establishing otsuka group environmental policy environmental activity guidelines promote action address issues reducing risk proactively addressing environmental issues f ga hil gu r ee sm ioe ne st groups environmental targets eg cutting p mu ar nsu ai gn eg e ef nfi tc se yn stt e mn sd highly effective action acquisition iso integrated certification environmental e bn uv sii nro en ssmental issues pursuing action cut ghg emissions throughout business value chains based establishment clear targets supply chain transparency riga hjo tsr n lao bn oc ro tm hep l eia nn vc ire nr ei ns tc cn od ru ruct p te iog n ir ne l ta ht ein sg u pto p lh yu cm haa n e c es sot tna adb bul li ics sh htii inn ngg g dt ah u ne e nit gls ogu iek nna gc g e r wo ou nhp ie n op rr io e nc l geu c sr ye snm tg ee mn sut pp po ii ec ry otsuka group sustainable procurement guidelines r pee old se tu c sc ei nn lg eg c tr u ii os pk np l mh ier oro nu iag tonh rd ie n ov ga n l ogu foa sit n uio g pn ps l iw erh sen failure appropriately allocate business resources strategic allocation managerial resources priority segments important measures business reducing risk strengthening risk holding company nc suo fm fip cil ee nte go vw er ro nn ag n cf eo r bm u hl oa lt dio inn g cr r mev pie aw ny n g clr uo du ip n gst gra rt oe ug py e gs lota bb al li ph oin lig ci ea groupwide oversight mechanism based otsuka group global code business ethics respective c ao dp oe nra gt oio inn g rm eio nn fog r g cero mu ep n tc om f gp ra uie ps company management strengthening internal monitoring framework establishing groupwide internal reporting system company management systems c reo pr ar ta oe n brand management insufficient corporate brand development management e f eos dt r ua cb aul ti ls ia oh ni n ag g n dh h e e tr c aoi nm iu na k gn f ogg r em u xe p en c p ut r tc vo g em u si ae nit l dt ine eee ms ployees r syne sd teu e mc si tn sag b lr ii ss hk nth gr inu fg oh rm tg ioo nin cg llr ea ci tn ii ng failure generate synergies due insufficient due diligence rii sg kn si f ci oc man mt business alliances acquisitions p fn oa lr u lt ofn wfe ic ir nis e g n ar na b c u aq cu qni ur ee sd ic oo nm nap ga en mie es nt engaging alliance c sto rn od nu gc et ri n bg u sc ia nr ee sf su ml ou ne oi rl ii ng ge n wc e nf eta nr gg ae gt nco gm inp ni e ia nd c ea os fos llowing acquisition r aned du mci ng tr ois rk b gy ss yt sr te en mg sthening screening business areas digitalization die gc il ti le iz ic oo nmpetitive ability due slow insufficient imd po rp ot vin ing g lt ia tete rao cf ah ne sr kt lt le c gh rn oo ul po g wie ids e c hn rd ou uc gt hin sg e mpr io arf af nc nc fe op rt ae tm ioo nn ss ht ara rit nio gns practical application r lae td eu stc tn eg ch r nis ok l ob gy ep sr aa nc dt ove ffl ey ra ind go p trt ing nth ge natural disasters pandemics nnu ats tep ure rr aun lps dto ion san tof e rp r dl oa e rn l p ao np de f er pa mrt oi io cdn us c e dt ec v e l lo os ps mof e nh tu dua en tr oe mo au jr oce r f c hor onm rd ou u ul ca gtt hnin g ig r b e pgu leus mi ln ee r n ds r ac nai n n odu f et cy x ep vrl ca idin se pc rlu evd ein ng ti oo nn g mo ein ag su r ev siew improvement r b kee us ed sa pu nt ic e nei sn r gs g ecc mei nns pk ta li r onb yuoy e isi en ya sc n po id nlr fp p n oo n rr n mia ndt egi e dn g ai ncn da nu tr oa l supply stability gle os bta ab l eli cz oa nt oio mn co f tm aga nte ar ti ia ol n p oro r c hu er ie gm hte en nt e dn gd e ou pp op iy ti cc aa lu rs ie sd k e ses v ca e ub r rs il ni f gh ic pg po rnn ph f ro ipu ars ee c iu nt ra ven emd na te nd rt ys ab na u ds c sed ps ro en c rg im ns g p pa u rn l otd di pg ule cd p ou npt p l cid oa rs sr sd ms n ud l ts ie pc lu e r min ag n ul ft ae cr tn ua rt ii nv ge sr ia tw es materials r sc ee e cd n uu rc ir ni gg r ldi ts ek v nb r ay si fr iy vu en n n rg ai n wug p v pa alr tei eo r rsu l snd patent infringement pnh rf oi rr pid n e g rp e ta ymr rt ey ign hn tf b sr yin tg em oe tn sut ko af gn rt oe ull pe c ot fu ta hl ip rdro pp ae rr tt yy ir nig teh lt ls ectual e us st ia nb gl dsh atin ag b aa em na dg em see rt c ha n ad g em cn ieit tr oin cg nsy ds ut ce tm ef ao rr c hn et se l ale nc dt u coal l lp ecro p ine fr oty rm ri ag th iots n r ad nu ac gin eg r ei nsk b dst mre ng th oe rin ni gn g ystems litigation l init si ug fa ft icio ien n b r lio tu igg ah tt io b ny ra e st ph oir nd eparty e cs ot oa pb eli rs ah ti og n wn tin ht oe urn tsa il r ee p coo urt nin seg l en td c cooperation system r sye sd teu mcin g nr dis k tb rey n e gs tt hab enlis inh gin cg pt ee rr ta il n major system outage establishing otsuka group global information security policy information management external cyberattack education training executives employees r lee vd eu lsc n og n gr ois ik n gth ir mou pg roh v h emig eh ne tr e ac nu dri ty falsification misuse leakage data negligence etc establishing group information security committee employee training part employee contractor thirdparty establishing emergency response system centered internal computer security incident response team csirt failure keep legal restrictions countries cooperation relevant departments implement appropriate management business operations based local operating reducing risk establishing systems global business operations group operates environments cooperation among operating companies sudden changes economic conditions business environment optimizing strategy longterm perspective based product local characteristics relevant departmentscontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report financial nonfinancial highlights profit attributable owners company return revenue overseas revenue ratio business profit business profit margin ratio revenue equity attributable owners company roe revenue overseas revenue ratio business profit business profit margin profit attributable owners company return equity attributable owners company roe billion billion billion plan plan plan revenue left overseas revenue ratio right business profit left business profit margin right profit attributable owners company left return equity attributable owners company roe right pharmaceutical business total assets ratio equity attributable rd expenses rd ratio ratio revenue owners company total assets annual dividend per share dividend payout ratio rd expenses pharmaceutical business total assets annual dividend per share billion billion plan plan rd expenses left total assets left annual dividend per share left rd ratio right ratio equity attributable owners company total assets right dividend payout ratio right excluding impairment lossescontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report financial nonfinancial highlights visit otsuka holdings website key sustainability data httpswwwotsukacomencsrdata nunmubmerb oef mofp leomyepesloyees nunmubmerb oef rf eomf aflee mmaanlea gmerasn faegmearlse mfeanmaageler rmataionager ratio emnpulomyebees rta okfin egm paprleonytael elesa tveaking parental leave outside japan japan number female managers left female manager ratio right female male scope production sites consolidated otsuka group scope fiscal six companies otsuka pharmaceutical otsuka pharmaceutical factory taiho scope fiscal six companies otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical otsuka warehouse otsuka chemical otsuka foods pharmaceutical otsuka warehouse otsuka chemical otsuka foods fiscal nine companies six companies plus otsuka pharmaceutical development fiscal nine companies six companies plus otsuka pharmaceutical development commercialization otsuka america pharmaceutical pharmavite commercialization otsuka america pharmaceutical pharmavite fiscal eleven companies nine companies plus otsuka holdings otsuka medical devices fiscal eleven companies nine companies plus otsuka holdings otsuka medical devices fiscal nineteen companies eleven companies plus otsuka electronics otsuka techno fiscal nineteen companies eleven companies plus otsuka electronics otsuka techno okayama taiho pharmaceutical otsuka packaging industries otsuka ohmi ceramics higashiyama film okayama taiho pharmaceutical otsuka packaging industries otsuka ohmi ceramics higashiyama film otsuka wellness vending jimro otsuka wellness vending jimro simple incineration landfill volume totcaol c oem eimssiisosinonss co emissions per sales wawtear tuesra guesa wgaete wr uastee erf fiucsieangcey per sales tottaol twaal swte avostluem veolume thousand tonsco tons million thousand million tons tons japan indonesia japan india southeast asia south korea east asia south asia north america north africa china north america europe south america others europe total co emissions left co emissions per sales right water usage left water usage per sales right simple incineration landfill left total waste volume right scope production sites consolidated otsuka group scope production sites consolidated otsuka group scope production sites consolidated otsuka groupcontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report esg content index addition information included integrated report otsuka group discloses following esgrelated information website please visit website details item policies commitments systems initiatives overall signatory united nations global compact sustainability mission materialities goals progress stakeholder engagement sustainability management structure external recognition data people environment governance society health basic policy pages pharmaceutical basic policy contribution unmet medical needs pages business goals progress initiatives access medicine fy goals quantification fy progress initiatives infectious diseases including tuberculosis pages nutraceutical basic policy catering yettobeimagined needs business goals progress initiatives access nutrition people basic policy human resource basic policy human resource development programs including management human resource development programs development internship programs systems leveraging abilities open recruiting system selfassessment system etc diversity otsuka group global code business ethics diversity inclusion systems diversity promotion including mindset establishing structure help diverse human resources play active roles regardless inclusion basic policy nationality race age gender disability sexual orientation etc signatory womens empowerment principles weps examples external recognition ikuboss managers supportive worklife balance declaration group companies health safety otsuka group global code business ethics initiatives employee health maintenance promotion human rights labor standards employee health initiatives workplace health safety basic policy initiatives reduction overtime encouraging employees take paid leave declaration health group companies examples external recognition health safety committee promotion structures fair employment otsuka group global code business ethics internal training bullying harassment issues working human rights labor standards discrimination harassment reporting concerns employee survey improvement activities based survey results condition basic policy human rights otsuka group global code business ethics implementing human right risk assessment identify salient human right risks initiatives human rights labor standards discrimination harassment reporting concerns identifying salient human right issues implementing corrective measures basic policy whistleblowing hotline otsuka group human rights policy employee training otsuka group human rights policy promotional structure external collaboration quality basic policy otsuka group global code business ethics business integrity maintaining books records etc certification status iso quality iso fssc food safety etc research commitments rd compliance laws guidelines ethical considerations etc ethical considerations research involving animals development ethical considerations research involving humanderived specimens ethical considerations research involving pathogenic microorganisms pathogens etc genetically modified organisms ethics clinical trials compliance rd otsuka group companies management public research funds procurement basic policy pages promotion sustainable procurement consideration environment human rights matters otsuka group procurement policy pages including due diligence investigation new suppliers common saq briefing sessions suppliers pages otsuka group sustainable procurement guidelines pages joint business collaborator audit pharmaceutical companies sustainable procurement promotional structure establishment otsuka sustainable procurement global initiatives streamlining production supply products task force goals progress pages production basic policy pages production quality control patientcustomer safety compliance regulatory requirements governmental industry quality control measures including global product quality policies pharmaceutical products nc global standards pages patient quality policy nutraceutical business otsuka pharmaceutical acquisition iso quality iso fssc food safety etc promotion structure including global production meeting global product quality meeting quality control based gqp gvp postmarketing safety management customer safety global implementation pharmacovigilance activities pages measures falsified medicines employee training logistics basic policy initiatives quality control maintenance promotion logistics compliance good distribution practice gdp guidelines establishment gdp promotion office promotion structures control maintenance employee training etc product quality stable supply logistics initiatives streamlined cooperation among shippers distributors standardization itbased data systems digitization forms etc initiatives stable supply distribution strage inventory registration vehicles authorized access restricted areas etc environmentally friendly measures promotion modal shift reduce co emissions etccontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report esg content index esg balance sheet also found website httpswwwotsukacomencsresgcontrolcharthtml item policies commitments systems initiatives sales basic policy conducting appropriate marketing promotion activities compliance laws regulations marketing establishing internal code practice expands jpmas promotion code prescription gathering disseminating information products related knowledge latest academic information etc drugs activities targeted healthcare professionals employee training structural measures establishing scientific affairs department gathering reducing food loss extending shelf life switching monthbased expiration dates etc disseminating information products related knowledge latest academic information dedicated review unit ensure appropriate marketing promotion activities customer basic policy promoting consumeroriented management service declaration consumeroriented commitment ensuring appropriate communication customers pages groupwide customer service liaison meeting crossdepartment listen customer feedback improved products based customer feedback pages meeting promotion structures consumeroriented management establishing dedicated contact points patients healthcare professionals customers environment environmental otsuka group global code business ethics environmental protection management otsuka group environmental policy otsuka group environmental activity guidelines group promotional structures centering otsuka group global environmental council disclosure iso certification status environmental vision net zero carbon basic policy initiatives efficient energy use co reduction expanded use renewable energy sources introduction cofree neutrality goals progress electricity including solar power generation inhouse consumption purchase green power certificates etc disclosure according tcfd recommendations disclosure co emissions data pages circular basic policy initiatives achieve zero waste economy goals progress initiatives plastic recycling disclosure waste volume effective use volume final disposal volume data water basic policy water risk evaluation manufacturing sites neutrality goals progress disclosure water usage unit sales data pages governance corporate basic policy governance corporate governance guidelines governance basic policy disclosure corporate governance report structure overview governance structure timeline initiatives strengthen corporate governance board directors audit supervisory board corporate governance committee rationale selection directors evaluation board effectiveness skill matrix directors audit supervisory board members pages succession plan remuneration basic policy disclosure corporate governance report directors remuneration standards system method determination audit supervisory board members compliance overall basic policy compliance promotion structure tax compliance basic policy correspondence tax authorities tax policy governance transfer pricing policy anticorruption promotion system due diligence otsuka group global code business ethics bribery corruption etc training employees otsuka group global anticorruption policy monitoring conflicts promotion system training employees interest otsuka group global code business ethics conflicts interest etc monitoring otsuka group global policy conflict interest protecting otsuka group global code business ethics privacy confidentiality etc training employees privacy otsuka group global privacy policy monitoring whistleblowing provision internal external whistleblowing hotlines hotline risk overall basic policy identifying significant risks via risk assessments mitigating risks management risk management policy business continuity planning management enterprise risk management risk management training risk management system initiatives mitigate information security risk contribution communities policy contribution communitiescontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report main data effect fiscal ended december otsuka adopted international financial reporting standards ifrs information fiscal ended december also presented line ifrs jgaap item unit results operations revenue billion selling general administrative expenses billion business profit rd expenses billion ratio business profit rd expenses revenue rd expenses billion rd ratio business profit billion business profit margin operating profit billion operating profit margin profit attributable owners company billion financial position total assets billion total equity billion ratio equity attributable owners company total assets roe cash flows net cash flows operating activities billion net cash flows used investing activities billion free cash flows billion dividends annual dividend per share yen dividend payout ratio common stock stock price thousand number shares outstanding yearend shares stock price yearend yen number employees total persons japan persons outside japan persons line items based ifrs due change consolidated fiscal year fiscal ended december transitional period sga expenses jgaap presented total expenses less rd expenses company believes covering nine months april december information useful investors comparing companys financial results jgaap ifrs december company finalized provisional accounting treatments business combinations excluding impairment losses reflected presentation figures year ended december business profit revenue cost sales selling general administrative expenses share profit associates calculated us rd expenses number employees including otsuka holdings co ltd subsidiariescontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report main data ifrs item unit unit results operations revenue billion us million selling general administrative expenses billion us million business profit rd expenses billion us million ratio business profit rd expenses revenue rd expenses billion us million rd ratio business profit billion us million business profit margin operating profit billion us million operating profit margin profit attributable owners company billion us million financial position total assets billion us million total equity billion us million ratio equity attributable owners company total assets roe cash flows net cash flows operating activities billion us million net cash flows used investing activities billion us million free cash flows billion us million dividends annual dividend per share yen us dividend payout ratio common stock stock price thousand thousand number shares outstanding yearend shares shares stock price yearend yen us number employees total persons persons japan persons persons outside japan persons persons contents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report group structure global network corporate information corporate information december otsuka group corporate philosophy company name otsuka holdings co ltd established july overview otsuka group companies whose origins date back aims contribute health people around world aims two main pillars pharmaceutical business diagnosis treatment diseases nutraceutical business capital billion support maintenance promotion everyday health companys culture summarized words ryukangodo sweat recognize way jissho actualization sozosei creativity fostered successive otsuka leaders emphasized employees across group companies countries regions strive create market unique products services head office kandatsukasamachi chiyodaku tokyo nutraceuticals nutritionpharmaceuticals end december otsuka holdings subsidiaries affiliates japan organizational structure otsuka holdings tokyo shinagawa grand central tower konan headquarters minatoku tokyo japan otsuka otsuka pharmaceutical taiho otsuka medical otsuka warehouse otsuka chemical otsuka foods pharmaceutical factory pharmaceutical devices telephone number global network consolidated employees december europe business control management related activities companies description respect companys subsidiaries affiliates operating pharmaceutical nutraceutical consumer product businesses north japan america otsuka operates middla es eia st etc companies companies countriesregions companies south group companiess central america oceania companies companies company organization overview main operating companies company organization otsuka pharmaceutical total healthcare company supporting wellbeing whole body co ltd treatment diseases promotion everyday health april corporate philosophy otsukapeople creating new products better health worldwide otsuka pharmaceutical operates two core businesses benefit peoples health pharmaceutical business provides new pharmaceuticals treatment diseases nutraceutical business provides products help people maintain improve health otsuka pharmaceutical original company otsuka group leader iv solutions factory inc japan years experience field based management vision best partner clinical nutrition otsuka pharmaceutical factory creates innovative products meet variety needs including pharmaceuticals medical devices oral rehydration solutions medical foods otc pharmaceuticals company operates globally focus japan rest asia taiho pharmaceutical half century working field oncology patients people worldwide co ltd taiho pharmaceutical rddriven specialty pharma focusing fields oncology allergy immunology urology corporate philosophy strive improve human health contribute society enriched smiles oncology field particular taiho pharmaceutical known one leading companies japan actively promoting globalization well consumer healthcare business taiho pharmaceutical strives create products support loving affluent lifestyle peoples needs utmost priority otsuka warehouse contributing peoples health worldwide field logistics co ltd since founding otsuka warehouse developed businesses emphasis pharmaceutical food product logistics includes constructing shared platform tailored otsuka groups three business domainspharmaceuticals foods beverages daily necessitiesand providing optimal logistics solutions joint distribution external manufacturers recent years otsuka warehouse utilized achieve connected logistics working reform distribution solutions otsuka chemical otsuka chemical creatively gives shape power materials together customers co ltd materials core operations otsuka chemical aims continuous technological innovation leads creation products enable higher standards living otsuka chemical provides products global markets automotive electrical electronic equipment housing healthcare areas main segments hydrazine business inorganic composite materials business pharmaceutical intermediates active pharmaceutical ingredient api business otsuka foods co ltd delivering revolutionary products new dietary styles since otsuka foods motto company begins people food begins spirit mind everyone otsuka foods brings spirit food focused deliciousness safety peace mind better health companys business food health main themes company striving create propose revolutionary products meet social needs aiming bring people joy happiness come good health otsuka foods seeks achieve sustainable growth contributing society otsuka medical devices developing innovative treatment methods creating new value co ltd since establishment february otsuka medical devices focused developing unique solutions improve health wellbeing patients whose medical needs conditions yet fulfilled existing treatment methods achieve aspiration becoming pioneer medical device industry company combines global rd efforts technology drug discovery knowhow inherent within otsuka groups heritage based otsuka groups corporate philosophyotsukapeople creating new products better health worldwideotsuka medical devices takes offer patients new innovative treatment choices contribute health healthcare people across world gniteem sredloherahs srotcerid fo draob namriahc tnediserp contents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report internal control department internal audit department nutraceutical business global strategy planning headquarters corporate planning department business insights analytics department cfo planning headquarters finance accounting department tax department corporate service department business development department investor relations department administration department president office public relations department sustainability promotion department human resources department corporate pension office human resource planning department planning department gxp support center legal affairs department statutory auditors board statutory statutory auditors office auditorscontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report disclosure otsuka group otsuka group provides overview financial nonfinancial information integrated report integrated report beginning fiscal edition otsuka holdings visit otsuka holdings website additional information including consolidated financial statements financial combined annual report csr report single integrated results presentations supplementary documents information research development report brings together financial information nonfinancial information hope deepens stakeholders understanding group aim become indispensable contributor peoples website otsuka groups sustainability health worldwide httpswwwotsukacomen httpswwwotsukacomencsr reporting period fiscal january december note certain information january onward also included scope reporting principle report covers otsuka holdings co ltd subsidiaries scope activities data narrower details noted guidelines referenced international integrated reporting framework international integrated reporting council iirc gri sustainability reporting standards global reporting initiative gri iso environmental reporting guidelines ministry environment guidance collaborative value creation ministry economy trade industry guidelines investor relations library precautions regarding forwardlooking statements httpswwwotsukacomencsrlibrary httpswwwotsukacomenir integrated report summarizes operating financial results otsuka group otsuka holdings co ltd subsidiaries sustainability handbook fiscal january december report handbook present examples contains forwardlooking statements forecast pertaining plans stance initiatives respect projections strategies performance otsuka group sustainability easily accessible format general public companies statements based upon current analysis beliefs light information available issuing date report actual results may therefore differ due risks uncertainties may affect otsuka group operations medical information environmental report integrated report sake readability unified brand compiled published detailed name used product different brand names different environmental report introduces otsuka groups environmental initiatives countries regions therefore products may available countries may available different brand names different indications different dosages strengths please note information regarding pharmaceutical products including products development intended advertising promotional purposes medical advicecontents otsukas value creation message ceo create value facts data otsuka holdings co ltd integrated report stock information december number shares authorized shares principal shareholders top maximumminimum stock price volatility year n nu um mb er r f sh ha ar es h ois ls du ee rd shares name shareholders sn h thu om ub e ahr ne dldf sh ra ar te ioho l di ng fiscal stom cka x pim ricu em stom ckin pim ricu em stav ndo ala rt dil dt ey v ion master trust bank japan ltd trust account nomura trust banking co ltd stock distribution otsuka founders shareholding fund trust account treasury shares securities otsuka estate co ltd companies custody bank japan ltd trust account companies otsuka group employee shareholding fund financial institutions awa bank ltd jp morgan chase bank jp morgan chase bank smbc nikko securities inc total shareholders return individuals others foreign otsuka asset co ltd corporations notes number shares held rounded nearest thousand fiscal lthough company holds shares treasury shares excluded list hareholding ratio calculated treasury shares deducted otsuka holdings comparison topix total return index stock performance stock price left trading volume right thousand shares